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ABSTRACT

Shedd, Elizabeth Ann. Guideline for Autism Screening in Primary Care. Unpublished
Doctor of Nursing Practice capstone project, University of Northern Colorado,
2017.
Autism spectrum disorder (ASD), once thought to be rare, is now considered
prevalent, with 1 of every 68 children diagnosed nationwide (Salley, 2016). There is no
treatment for ASD, but early therapeutic interventions can help children with ASD live a
higher quality of life and achieve major developmental milestones such as language
development (Dreyer, 2016). Because ASD can challenge all members of a family, early
identification and intervention is vital. This process improvement project was created to
enable higher rates of detection for ASD and other developmental delays. The major
process improvement intervention was implementing universal screening for ASD during
all well-child exams between 18 and 24 months. A guideline was created to help
providers know when to screen, what screening tool to use, and how to respond if the
screening is abnormal. An educational seminar for all staff involved in the care of
pediatric patients also occurred. A chart audit of the guideline and algorithm’s clinical
use was done to evaluate the successes of the project. To further evaluate outcomes, a
staff and provider basic ASD knowledge survey was conducted before and after the
education was provided. Finally, steps were taken to work with IT from the electronic
health record (EHR) to integrate documentation prompts for providers to ease the use of
ASD screening and appropriate billing. With the conclusion of this project, all data
iii

acquired indicated the clinical guideline, algorithm, and educational platform were a
success. Screening for ASD increased after the implementation. Furthermore, provider
and staff knowledge regarding ASD and ASD screening was enhanced. Further work
with this type of process improvement project should be conducted, as indicated with the
findings of this study.
Keywords: Autism Spectrum Disorders, M-CHAT R, universal screening
algorithm
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CHAPTER I

PROBLEM STATEMENT AND PURPOSE

Autism spectrum disorder (ASD) is a class of neurodevelopmental disorders that
affect children and adults. As of yet, there is no cure for ASD but early intervention
including therapy and education might improve the lives of those living with ASD
(Bradshaw, Mossman-Steiner, Gengoux, & Kern-Koegel, 2015). Historically, ASD has
been difficult to identify early in primary care (Barton, Dumont-Mathieu, & Fein, 2012).
Because of this, delayed diagnosis is all too common. When delayed diagnosis occurs,
early intervention and treatment do not happen.
The median age for diagnosis of ASD is over four-years-old (Augustyn, 2016b).
Challenges of early identification include time constraints at a typical office visit, the
vague nature of social developmental milestones, and the variability of signs and
symptoms in children suspected with ASD (Augustyn, 2016a). Cases of ASD range from
mild to severe (Johnson, Myers, and American Academy of Pediatrics Council on
Children with Disabilities, 2007). With this being said, appropriate diagnosis of ASD is
imperative to enhance specific therapies catered to an individual child’s disability.
Surveillance for ASD in the primary care setting should begin at nine months and
continue throughout the child’s youth (Johnson et al., 2007). Screening is often done by
use of the Modified Checklist for Autism in Toddlers-Revised (M-CHAT R) between 18
and 24 months of age (Coury, 2015). The M-CHAT R is one of the most widely used
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ASD screening tools (Johnson et al., 2007). In practice, early identification of red flags
and subsequent screening are clearly variable. Screening practices vary widely not only
between clinics but also between providers within any given clinic. For example, some
practice sites complete well-child exams with no screening for ASD.
Even with valid and inexpensive screening instruments available, early
identification and prompt referral by primary care providers are poor (Robins, 2008).
Unfortunately, lack of recognition and referral lead to delayed diagnosis and therapy,
both of which contribute to less favorable outcomes for children with ASD (Robins,
2008). The purpose of this process improvement project was to increase education of
providers and their awareness of ASD screening.
Background and Synthesis
Autism spectrum disorder is a spectrum of neurodevelopmental disorders
(Augustyn, 2016b). In the past, ASD included four subtypes: autistic disorder,
Asperger’s disorder, childhood disintegrative disorder, and pervasive developmental
disorder not otherwise specified (American Psychiatric Association [APA], 2013). The
fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (APA, 2013)
published new recommendations regarding the classification of ASD. Currently, the
range of diagnoses for ASD falls on one spectrum with no subtypes. The single spectrum
helps ensure all children, even those with mild phenotypes, can access therapies
appropriate for their needs (APA, 2013).
It is often difficult for providers to conceptualize all the symptoms of ASD due to
the spectrum of phenotypes (Centers for Disease Control and Prevention [CDC], 2010).
Autism spectrum disorder in any form impacts day-to-day functioning and affects quality
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of life (Robins, 2008). Patients who are diagnosed with ASD have two distinct
characteristics: (a) deficits in social communication and interaction, and (b) restricted,
repetitive patterns of behavior, interests, and activities (Augustyn, 2016a). Those with
ASD often struggle with functioning in society because of all the deficits that accompany
ASD. A few of these challenges include limited communication skills, restricted and
repetitive behaviors, and social deficits (CDC, 2010).
Estimates of ASD prevalence vary with different study methodologies and
populations, making it difficult to come to an accurate conclusion about several
epidemiological data points (Augustyn, 2016b). Autism spectrum disorder is four times
more common in males than in females (CDC, 2010). Recent studies indicate ASD in the
United States occurs from approximately 1 in 50 to 1 in 500 people (Augustyn, 2016b).
Risk factors for ASD include siblings with ASD, tuberous sclerosis complex, Fragile X,
Rhett syndrome, various metabolic conditions, Smith-Lemli-Opitz syndrome, and 15q
deletions, duplications, triplications, and known chromosomal hot spots (1, 2, 3q, 5p, 7q,
11q, 12q, 13q, 16p, 17, 18q, 21p, 22q, and X; Augustyn, 2016b). Table 1 presents a
breakdown of some of the known chromosomal hot spots, chromosomal changes, and
known phenotypic changes seen with chromosomal abnormalities (National Institutes of
Health, 2016a). At this time, due to on-going extensive research regarding genetic
changes in ASD, experts do not know all the phenotypic changes noted in all the hot
spots.
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Table 1
Known Chromosomal Hot Spots with Phenotypic Changes
Cytogenic Deletion/Duplication Phenotypic Change
Location
1
Microduplication
Developmental delay and
intellectual delay

Reference

3p

Both

NIH, 2016b

7q

Both

Deletion of axon connection in
the developing nervous system
DNA building blocksunknown phenotypic change

15q

Microdeletion

Intellectual disability, seizures,
behavioral problems,
psychiatric disorders

NIH, 2016d

16p

Both

Developmental delay and
intellectual disability

NIH, 2016e

22q

Deletion

Developmental delay,
intellectual disability,
hypotonia, absent or delayed
speech

NIH, 2016f

NIH, 2016c

NIH, 2016a

Although there is a genetic component to ASD, researchers have yet to unlock all
the genetic factors that contribute to the development of ASD (Koch, 2014). What is
known is genetic factors do play a role in the different phenotypes seen in the spectrum of
the disorder (Koch, 2014). The pathogenesis of ASD is not completely understood,
making the general consensus of the disorder etiologies to include genetic, congenital,
neurobiological, and possible environmental factors (Augustyn, 2016b). Other factors
that might contribute to ASD include maternal use of certain medications and advanced
maternal age (Koyama, Kamio, Inada, & Inokuchi, 2011). According to Gardener,
Spiegelman, and Buka (2009), more research must be done regarding maternal
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medication use and risk of ASD. However, as of date, researchers know maternal use of
psychoactive drugs increases the risk of ASD (Goldstein, Naglieri, & Ozonoff, 2009).
“Although they observed no significant association for antiepileptics, antihypertensives,
cardiovascular drugs, tocolytics, nor use of steroids, a significant 60% increased risk of
autism was observed in relation to use of psychoactive drugs” (Gardener et al., 2009, p.
9).
Currently. the number of ASD diagnoses is increasing (Suresh, 2016). While this
appears to be a dichotomy, increases in ASD diagnoses would typically indicate greater
identification from providers. However, with ASD this is not the case (CDC, 2010).
Increases in ASD diagnosis are believed to be related to changes in diagnostic criteria,
increased awareness, changes in study methodology, or a combination of these factors
(Augustyn, 2016a). With an increase in ASD seen in children, there is an even greater
push to identify ASD early in primary care settings (Daniels, Halladay, Shih, Elder, &
Dawson, 2014).
In the primary care setting, screening for ASD is a challenge because of limited
visit time, lack of education, lack of resources, vague nature of symptoms, lack of
discussion regarding the achievement of milestones, and large variability of symptoms
(Augustyn, 2016a). Delayed diagnosis is a concern as it can delay early intervention.
Several different screening tools can be utilized by primary care providers for primary
screening. Current recommendations for screening are screening for red flags at every
well-child visit, conduction of developmental screening tests between 9 and 30 months,
conducting autism-specific screening between 18 and 24 months, and raising any
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developmental concerns by caregivers (Dreyer, 2016). Table 2 provides a summary of
valid screening tools for ASD in primary care.

Table 2
Screening Tools for Autism Spectrum Disorder
Tool

Age

Description

Sensitivity and
Specificity in Percentage

M-CHAT R

16-30 months

•
•

20 parent-report items
Takes approximately 5 minutes to
administer and 2 minutes to score

Sensitivity: 85
Specificity: 99

STAT

24-36 months

•

12 observed activities during a 20minute play session
Requires training for administration
and scoring

Sensitivity: 92 to 95
Specificity: 73 to 85

7 item parent-report items, a
component of the Survey of
Wellbeing of Young Children
(SWYC)
Takes ≤ 5 minutes to complete

Sensitivity: 83
Specificity: 74

40 parent-report items (yes/no)
Takes < 10 minutes to administer and
< 5 minutes to score

Sensitivity: 85
Specificity: 75

•

POSI

18-35 months

•

•
SCQ

4-40 years

•
•

CAST

4-11 years

37 parent reported items

Accuracy varied with
case definition

ASSQ

7-16 years

27-item checklist to be completed by
parents or teachers and takes about 10
minutes to complete

Sensitivity: 91
Specificity: 86

AQ

4-11 years

Parent report measure

Sensitivity: 95
Specificity: 95

DBC-ASA

4-18 years

29 parent-report items from the DBC-P

Sensitivity: 86
Specificity: 79 (with cutoff score of 17)

DBC-ES

18-48 months

17 parent-report items from the DBC-P

Sensitivity: 88
Specificity: 69
Note. M-CHAT R = Modified checklist for Autism in toddlers with revised follow-up; STAT = Screening
for Autism in Two-Year-Olds; POSI = Parents-Observations of Social Interactions; SCQ = SocialCommunication Questionnaire; CAST = Childhood Autism Syndrome Test; ASSQ = Autism Spectrum
Screening Questionnaire; AQ = Autism Spectrum Quotient; DBC-ASA = Developmental Behavior
Checklist Autism Screening Algorithm; DBC-ES = Developmental Behavior Checklist Early Screen

Source. Bridgemohan, 2016a, pp. 13-14
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These screening tools include M-CHAT R, screening for autism in two-year-olds
(STAT), infant-toddler checklist, parent-observations of social interactions (POSI),
social-communication questionnaire (SCQ), childhood autism syndrome test (CAST),
autism spectrum screening questionnaire (ASSQ), autism spectrum quotient (AQ),
developmental behavior checklist autism screening algorithm (DBC-ASA), and
developmental behavior checklist early screen (DBC-ES; Barton et al., 2012).
The M-CHAT R was developed for primary care providers to identify suspected
cases of developmental disorders (Robins, 2008). When a suspected case is identified,
the child is then referred to a developmental pediatric specialist who administers further
testing to narrow down what type of developmental delay the child might have. The
instrument utilized to diagnose ASD varies between providers and is considered with the
patient’s gestational and chronological age (Robins, 2008). In the primary care setting,
M-CHAT R is the most widely used questionnaire (Robins, 2008) because it is quick to
administer and score, feasible and accurate, free to providers and parents, and is
recommended by the American Pediatric Association in practice (Dreyer, 2016).
Unfortunately, both general developmental screening tools and autism-specific
screening tools have limitations. For example, they have limited sensitivity, which
restricts the tool’s ability to identify young children with ASD (Barton et al., 2012).
Available tools also have a low specificity, which limits the ability to discriminate ASD
from other developmental disorders (Robins, 2008). Another concern is tools largely rely
on parental reports that can be inaccurate, particularly when screening older children
(Barton et al., 2012). For these reasons, screening and diagnosis of ASD is a challenge
for primary care providers. With an abundance of different screening tools, all with
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limited specificity and sensitivity, restrictive time during office visits to perform
screening, and lack of education for providers regarding high-risk populations and red
flags, delayed diagnosis among suspected ASD children might be all too common.
Improving provider education regarding knowledge of high-risk populations and red flags
is a modifiable challenge. Furthermore, by improving provider knowledge, restrictive
office time could be somewhat alleviated by quicker screening time because of improved
knowledge.
As discussed previously, surveillance for ASD should occur at every well-child
check starting at nine months (Johnson et al., 2007). Furthermore, the focus of the
provider is to identify any red flags and then perform further screening as necessary. Red
flags of ASD help providers identify potential risks of developmental delay and ASD.
Subsequently, further screening can be performed using an appropriate age-related
screening tool or referral to an ASD expert if necessary. Known red flags of ASD are as
follows:
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Delayed language and social/communication skills
No babbling by nine months
No single words by 16 months
Avoids or inconsistent eye contact
Repeats or echoes words or phrases said to them or heard on TV
Has trouble requesting or expressing needs through typical words or
gestures
No spontaneous, meaningful (not repetitive or echolalic) two-word phrases
by 24 months
Any loss of language or social skills at any age
Lack of orientation to name by 12 months
Lack of pretend or symbolic play by 18 months
No pointing gestures by 12 months
Restrictive and repetitive behaviors
Parental concerns about deficits in social skills
Parental concerns about deficits in language skills or behavior
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•

Parental concerns about frequent temper tantrums or intolerance to change.
(Bridgemohan, 2016b, p. 14)

Recently, the U.S. Preventive Services Task Force (USPSTF) published revised
recommendations that state, “The USPSTF found insufficient evidence on screening for
ASD in children aged 18 to 30 months for whom no concerns of ASD have been raised
by parents, other caregivers, or healthcare professionals (I statement)” (Siu et al., 2016, p.
315). Because of the newly published recommendations about ASD screening, more
education for providers, patient care guidelines, and referral and treatment algorithms
need to be established for primary care settings to identify high-risk behaviors, times to
screen using the autism-specific screening tools, and times to appropriately refer for those
screening positive. Identifying these times would promote prompt identification and
early interventions for ASD. In light of the USPSTF recommendations, the American
Academy of Pediatrics (AAP) still recommends universal screening at 18 and 24 months
due to extensive evidence to support these actions:
Although the USPSTF report found evidence for valid screening tools to detect
ASD in toddlers and evidence that early intervention has positive effects on
prognosis for children, they concluded that the lack of studies showing long-term
outcomes from ASD screening means that there is insufficient evidence for
universal toddler screening for ASD. (Robins et al., 2016, p. 1880)
For this reason, process improvement strategies must be implemented to improve
early detection, increase prompt referral to early intervention, and evaluate long-term
outcomes. Having two organizations recommending different screening measures adds
confusion and frustration to diagnosing this already complicated disorder. The USPSTF
(Siu et al., 2016) recommendation indicates evaluation should occur in instances where
concerns have been discussed either by caregivers or other medical professionals
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regarding ASD. The barrier to the USPSTF recommendation, however, is caregivers and
healthcare professionals alike are not routinely educated regarding ASD red flags and risk
factors. According to Rhoades, Scarpa, and Salley (2007), some healthcare professionals
have less than adequate training with regard to ASD surveillance. Their study helped
provide evidence that more education for medical professionals is necessary. “We
recommend that all physicians receive specialized training about ASD to improve upon
early screening and diagnosis, and then advise caregivers about empirically-supported
services” (Rhoades et al., 2007, p. 1). With the evidentiary support discussed, it was
advisable for this study to remain in-line with the AAP universal ASD screening
recommendation.
Early screening leading to early intervention is vital to encourage higher quality
communication skills as well as child-specific education programs, to decrease
challenging behaviors, and to enhance the family’s quality of life. Early intervention and
therapy can occur at early intervention programs, school-based special education
programs, or by therapists in private settings (Bradshaw et al., 2015). Behavioral and
educational interventions are aimed to address deficits in communication, social
interactions, interests, and activities (Bradshaw et al., 2015). Psychopharmacologic
interventions can also address anxiety, depression, and other symptoms like insomnia or
constipation (Bridgemohan, 2016c). “There is increasing evidence that intervention is
more effective when initiated as early as possible. The establishment of appropriate
management strategies in the early years can help to minimize or even avoid subsequent
behavioral problems” (Bridgemohan, 2016c, p. 2). Many specialists are involved in early
ASD intervention: developmental pediatricians, child neurologists, child psychiatrists,
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psychologists, genetic counselors, speech language pathologists, occupational therapists,
audiologists, and social workers. The primary care provider plays a large role in caring
for children with ASD in initial identification, caring for the family, and ongoing
management of routine care. Early identification by the primary care provider is perhaps
the most important role in the promotion of positive outcomes for ASD children and their
families (Barton et al., 2012).
An important consideration of ASD is other symptoms that accompany ASD. For
example, constipation and insomnia are common symptoms seen in ASD. This is a grave
concern for caregivers and patients alike. Lack of sleep for all parties involved can cause
depression, fatigue, and anxiety. “In typically developing children sleep problems and
insufficient sleep can result in daytime sleepiness, learning problems and behavioral
issues such as hyperactivity, inattentiveness and aggression” (Lamm, 2016, p. 1). Figure
1 provides a high-quality summary of the symptoms that can be seen with ASD and are
important to consider as a primary care provider. All these factors contribute to the vital
importance of early diagnosis and intervention because early intervention has the
potential to improve quality of life for children and families.
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Figure 1. Symptoms of autism spectrum disorder (Lamm, 2016, p. 1).

Parent-reported screening tools play an important role in the care of pediatric
patients (Dreyer, 2016). The M-CHAT R and M-CHAT R/F are parent-reported
screening tools that can be universally given usually at 18 and 24 months but can also be
given up to 30 months (Robins, 2008). These tools screen for ASD in those at risk for
ASD or those with developmental delays (Robins, 2008). Both instruments are free and
can be found online (Dreyer, 2016). Both screening tests are feasible, simple to use,
accurate, and recommended by the AAP in practice (Dreyer, 2016).
The M-CHAT R takes five minutes to administer and score. The M-CHAT R/F
takes 10 to 15 minutes to administer and score (Robins, 2008); it is given only at followup appointments after the M-CHAT R has been administered and results are shown to be
positive or abnormal (Robins, 2008). The M-CHAT R/F is a two-staged tool similar to
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the M-CHAT R instrument, which can be utilized from 16 to 30 months of age (Robins,
2008). The first part of the instrument includes 20 questions designed to address core
symptoms of ASD (Robins, 2008). The test takes five minutes to administer and two
minutes to score. The second part of the exam is a follow-up questionnaire that seeks
additional information and examples of any high-risk behaviors (Robins, 2008). The
second stage of testing takes 5 to 10 minutes to administer. If a child scores medium or
high from the first stage, then the second stage of the tool is to be administered. If the
second part of the M-CHAT R/F is positive or if the first part scores 8 to 20, then
immediate referral for diagnostic evaluation and early intervention is appropriate
(Robins, 2008). The M-CHAT R is provided in Appendix A.
Literature Review
Robins’ (2008) research study was important for this type of process
improvement project. The study was conducted from March 2005 to October 2007 in
Metro-Atlanta (Robins, 2008). It focused on children ages 16 to 26.9 months to cover
any overlap from 18 months to 24 months in well-child exams. The purpose of the study
was to evaluate if M-CHAT R and M-CHAT R/F were effective in the identification of
ASD in primary care (Robins, 2008). The outcome of the study indicated level-one
screening for ASD in primary care was feasible. “Therefore, the positive predictive value
(PPV) for M-CHAT R plus interview was calculated as 21 of 37 screen-positive
completed cases, which brings the PPV to .57” (Robins, 2008, p. 552). These findings
indicated a substantial portion of the overall sample size (n = 4,797) with a positive
screen on the M-CHAT R also screened positive on the M-CHAT R/F and were
subsequently diagnosed with ASD by a specialist (Robins, 2008). Furthermore, findings
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of the study indicated primary surveillance without ASD specific screening at 18 and 24
months was not sufficient enough to identify and refer those with suspected ASD or other
developmental delays (Robins, 2008). As mentioned in the background, primary
surveillance is a hyperawareness of ASD red flags and risk factors; consistently
monitoring for any abnormalities should occur at every appointment. The recent
USPSTF (Siu et al., 2016) recommendations on ASD screening could be argued with this
research study, which indicated there was sufficient evidence to screen for ASD in
primary care rather than just utilizing primary surveillance for ASD awareness (Robins,
2008).
Robins’ (2008) work is important to consider when implementing a guideline for
universal ASD screening in primary care because it demonstrated the M-CHAT R had a
high PPV and was feasible to implement. The one factor not discussed in current
available research was provider satisfaction related to use of this screening tool (Robins,
2008). There is provider resistance any time a provider must take more time away from
subjective and objective provider practice to administer another screening.
Unfortunately, Robins does not discuss the feasibility of implementation in practice from
the provider’s viewpoint. Although false positives in the study were not diagnosed with
ASD, developmental delays might still need to be evaluated, addressed, and documented
(Robins, 2008). If a child is not diagnosed with ASD, this does not mean speech therapy
is not indicated for speech delays. An evidence-based guideline is key to provider buyin. Robins helps to prove the M-CHAT R and M-CHAT R/F are feasible to utilize as
level-one universal ASD screening along with primary surveillance to combat delayed
diagnosis and intervention for ASD.
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This conclusion is consistent with the recent AAP policy statement and autismspecific screening guidelines which call for ASD specific screening at 18- and 24month well-child visits, alongside routine ASD surveillance and broad land
screening for other developmental disorders. (Robins, 2008, p. 552)
Implementing a guideline for universal screening has the potential to provide
plenty of provider strain and ancillary staff frustration. By streamlining the process and
supporting the integration of autism-specific screening into primary care by high-quality
research, stakeholder buy-in could be simplified. Barton et al.’s (2012) work aimed to
simplify the process by reviewing all of the screening tools currently in use in addition to
providing specific recommendations of each. Their systematic review provided a
thorough review of literature on the best timeframe to screen for ASD as well as the
importance of early screening, which was vital to this project. “The use of formal screens
in addition to primary care surveillance appears to augment the effectiveness of
surveillance in identifying children with ASD and reduces disparities between racial and
ethnic groups” (Barton et al., 2012, p. 1166).
Barton et al.’s (2012) research supports the AAP recommendation for universal
screening at 18 and 24 months along with primary ASD surveillance: “Therefore,
screening at 18 months and again at 24 months, is likely to identify the largest number of
children without compromising specificity” (p. 1167). To support the use of universal
screening using a screening tool, criteria for the quality of the screening tool are needed.
With regard to the M-CHAT R, sensitivity and specificity are reported to be high with
levels of accuracy at .87 and .99, respectively (Barton et al., 2012). Acceptable
sensitivity, specificity, and PPV signify a high-quality instrument supported for use with
patients.
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Another interesting component to Barton et al.’s (2012) systematic review was the
discussion about barriers to ASD screening in primary care. This discussion could help
combat any barriers to implementing a guideline for screening in primary care. The
common theme addressed by all providers with regard to screening was demand on
provider time and task to time ratio (Barton et al., 2012). Providers do not have enough
time to address all components of disease prevention and lifestyle management in a
single appointment. On top of this, providers experience staff shortages and frequent
turnover. Ancillary staff are vital to patient care and necessary to implement autismspecific screening in primary care (Barton et al., 2012).
As discussed previously, known disparities in the screening for ASD disorders
and other developmental delays are based on race, ethnicity, and socioeconomic status
(Barton et al., 2012). By implementing universal screening on all 18- and 24-month
well-child exams, this disparity could be alleviated. Barton et al. (2012) discussed this
disparity in length; by reviewing data on ASD screening, their recommendation was inline with AAP’s recommendation to universally screen:
When providers use validated screening tools to begin a process of discussion and
referral, they support all parents in further understanding early development and
securing the resources that they may need to facilitate each child’s optimal
development. (p. 1172)
To have improved provider and patient results when implementing a guideline for
autism-specific screening, there must be concrete evidence the process change is
beneficial, evidence-based, and feasible. Daniels et al. (2014) conducted a systematic
review of literature to provide the support necessary for practice change. The
methodology for this review included a search of peer-reviewed and gray literature from
January 1990 to January 2013 where ASD testing approaches were utilized to increase
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early detection (Daniels et al., 2014). The search discovered 40 studies using 35 different
methods of autism-specific screening. These studies were divided into the following
categories: awareness, routine screening, and practice improvement to enhance screening.
Twenty-five studies used 21 screening approaches directly related to routine screening
(Daniels et al., 2014). Of the 25 studies, 22 implemented routine screening during wellchild visits only. The two most common screening methods included the Ages and
Stages (ASQ3) questionnaire and the M-CHAT R (Daniels et al., 2014).
The outcomes of the studies were all positive with regard to increasing overall
provider awareness, referral, and diagnosis of ASD and other developmental delays
(Daniels et al., 2014). “With respect to referral rates, one study found a 224% increase in
post-intervention, and another documented a significant increase among 3-year old
children only” (Daniels et al., 2014, p. 149). By implementing universal screening, there
was an increase in awareness, referral rates, diagnosis, improvement of delayed
diagnosis, and referral to early therapy. These data showed by performing universal
screening for ASD, positive outcomes were more likely to occur (Daniels et al., 2014).
Missed opportunities for early intervention are all too common in primary care. By using
the M-CHAT R, M-CHAT R/F, and by following the guideline provided from this
process improvement project, missed opportunities could be drastically reduced (Daniels
et al., 2014).
This systematic review of literature was important for this project because it
provided solid evidence necessary to prove change needed to happen and change was
feasible (Daniels et al., 2014). With the USPSTF (Siu et al., 2016) publishing new
guidelines that stated there was insufficient evidence and with the AAP (Dreyer, 2016)
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saying there was sufficient evidence, Daniels et al.’s (2014) systematic review supported
the AAP recommendation: “For the most part, studies implementing routine screening
found high (>80%) or significantly increased screening and referral rates” (p. 148). With
a disorder like ASD and developmental delays, early intervention is the only way to
improve the quality of life for these children (Daniels et al., 2014). If primary care
providers do not screen, children lose the opportunity for early intervention. Routine
screening in primary care is key to reducing delayed diagnosis and improving
developmental outcomes and quality of life (Daniels et al., 2014).
Bradshaw et al.’s systematic review (2015) was the concluding piece for this
literature review. To implement universal screening for ASD in primary care, treatments
and interventions for the disorder need to be available, feasible, and effective; otherwise,
screening is wasteful. There must also be adequate physician buy-in, ease of transition,
and physician satisfaction. As mentioned previously, early therapy is the only current
intervention provided to those believed to have the disorder or those at risk for
developmental delay (Bradshaw et al., 2015). Bradshaw et al.’s systematic review
provided the evidence regarding the feasibility and effectiveness of early intervention for
toddlers--the target age population for this process improvement project (well-child
exams at 18 and 24 months).
Bradshaw et al.’s (2015) systematic review focused on reviewing interventions
utilized in infants and toddlers under 24 months of age at risk or who had ASD. Nine
studies were reviewed for participants, intervention approach, experimental design, and
outcomes. The outcome of the studies unanimously indicated early intervention is
feasible and effective in infants and toddlers (Bradshaw et al., 2015). “These studies
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highlight the feasibility of very early intervention and provide preliminary evidence that
intervention for at-risk infants may be beneficial for infants and parents” (Bradshaw et
al., 2015, p. 778). Early intervention begun in infancy is vital as it is when early
intervention is most impactful. “Beginning at birth, early attentional preferences for
social stimuli foster the emergence of social communication” (Bradshaw et al., 2015, p.
779). When utilizing universal screening for ASD and other developmental delays, there
must be proof the process change will have a positive impact. Bradshaw et al.’s
systematic review provided evidence backed by research that if ASD was identified early
by routine screening, early intervention was feasible and effective. Early ASD
identification through routine screening allows a higher quality of care be provided to
children (Bradshaw et al., 2015).
To conclude, the review of the ASD specific literature provided a summary
focusing on the impact of universal screening for ASD and other developmental
disorders. The screening process could be simplified with the use of standardized and
valid screening tools such as the M-CHAT R and M-CHAT-R/F due to simplicity in both
administration and scoring (Robins, 2008). The M-CHAT R and M-CHAT R/F are highquality instruments when considering PPV, specificity, and sensitivity discussed in
Daniels et al.’s (2014) research. In addressing a process improvement change, staff and
provider challenges must be addressed. Barton et al. (2012) provided a thorough
discussion of these challenges. By highlighting these challenges early, process
improvement changes can be implemented with ease because the challenges and
frustrations are tackled head on.
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Daniels et al.’s (2014) research was vital to this project because it provided a
systematic review of ASD screening that backed the use of universal screening in
primary care. Their research also lent support to AAP (Dreyer, 2016) recommendations
for autism-specific screening. Bradshaw et al.’s (2015) systematic review argued
universal screening is important because early intervention is effective and feasible.
Routine screening for ASD and other developmental disorders is vital in primary care
because it enables early identification and early intervention; it also combats the burden
of disease, improves quality of life, and enables developmental milestone successes
(Daniels et al., 2014; Robins, 2008).
The purpose of this study was to directly combat the barrier of delayed ASD
diagnosis. Implementing universal ASD screening at every well-child visit at 18 and 24
months using the evidence-based M-CHAT R screening tool at a clinic where no
screening occurs was the process change of this study. Following the AAP (Dreyer,
2016) ASD screening recommendation, while also taking into consideration the
information gathered in the literature review, this study was evidence-based and doable
within primary practice.
Synthesis Summary
Surveillance and screening for ASD in the primary care setting is vital to promote
health, decrease the burden of disease, and improve the quality of life for children with
ASD and their families (Daniels et al., 2014). Early screening and identification of ASD
is the most critical role primary care providers can play (Robins, 2008). If delayed
diagnosis of ASD occurs, then early intervention is withheld. Primary care providers are
the key to decreasing the rate of delayed diagnosis of ASD in children (Barton et al.,
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2012). By establishing a guideline and algorithm for surveillance and screening in the
primary care setting, providers can consistently provide high-quality, prompt diagnosis
and intervention for ASD.
Theoretical Framework
Creating a guideline for a primary care setting required consideration of the
impact a potential practice change might have on the facility. By utilizing the Stetler
(2001) model, any practice changes that arose from the guideline were considered,
addressed, and evaluated. The Stetler model is a research utilization model that can be
applied to an individual practice of providers. It ultimately allows providers to
incorporate research findings into their individual practice (Stetler, 2001). This model
follows six phases that allow for research to enter practice:
•

Phase I: Preparation

•

Phase I: Validation

•

Phase III: Comparative Evaluation

•

Phase IV: Decision Making

•

Phase V: Translation and Application

•

Phase VI: Evaluation

These six phases facilitate the implementation of research. The Stetler (2001)
model allocates the following: (a) time for research with preparation, (b) validation of
research by extensive literature reviews and a comparative evaluation if applicable, (c)
decision making with providers by presenting the research, (d) translating the research to
a practice change and applying any practice changes to practice, and (e) evaluating the
effectiveness or even flaws of the practice change. By following the Stetler model, any
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evidence-based practice guidelines could be created, implemented, and evaluated without
making provider practice more challenging. The Stetler model was used to create the
guideline for ASD screening in the primary care setting (see Figure 2).

Figure 2. Updating the Stetler model of research utilization to facilitate evidence-based
practice (Stetler, 2001, p. 273).

Nursing Theory
Nursing theory is an important component to consider when creating an evidencebased capstone project. In consideration of ASD, developmental delay, and families,
nursing theory is a key component in creating a meaningful project that improves the
delivery of health care, decreases the burden of disease, and helps providers be
empathetic and care for the families as ASD is a challenging disorder. Mishel’s (1990)
middle-range nursing theory was easily applied to this project (see Figure 3).
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Figure 3. Reconceptualization of the uncertainty in illness theory (Mishel, 1990, p. 256).

The theory was originally created for cancer and chronic-illness but has since
evolved (Mishel, 1990). Now, it can be applied to those with cancer, chronic illness, lifethreatening illness, and psychological responses to disease. The theory’s focus is
managing the uncertainty that can accompany disease (Mishel, 1990). Disease, including
neurodevelopmental disorders like ASD, as a concept is challenging, even with selflimiting disease. No outcome is ever certain with health care. With ASD, so much
uncertainty plagues all parties involved. Even with early intervention, uncertainty is
rampant; however, with an available evidence-based screening guideline to enhance early
diagnosis and intervention, the uncertainty of ASD can be addressed aggressively to
achieve the highest quality of life possible for patients and families.
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CHAPTER II

PROJECT OBJECTIVES

Objectives for the capstone project were built upon the preceding review of
literature. Other important components that built upon the preceding literature review
were consulting with experts in the field and critiquing numerous resources regarding
guidelines for autism in the primary care setting. By performing the necessary
groundwork, the highest quality guideline and algorithm for ASD screening at a primary
care clinic was developed.
There were three main objectives for this project. The first objective of the
project was to compile all the information gathered during research to create a guideline
and algorithm a primary care clinic could utilize for universal ASD screening. To
complete the first objective, it was imperative to work with the clinic manager, medical
assistant (MA), and nurse practitioner (NP) staff to make the guideline and algorithm
system-specific to fit their needs. The second objective was to work with information
technology (IT) to improve electronic health record (EHR) documentation of ASD
screening for the same primary care clinic. The third objective was to evaluate the
effectiveness of guideline implementation.
To evaluate the outcome of the project and the use of the guideline and algorithm,
a chart audit was performed. Secondly, due to the evaluative nature of the educational
program, the clinic staff including all providers and MAs were asked to complete a
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survey before and after the educational offering. These two outcome objectives provided
a thorough summary of the successes of this process improvement project.
Intervention Plan
By using evidence-based practice, the focus of this project was to create a
guideline and algorithm for primary care settings with regard to ASD screening. The
guideline was created utilizing a literature analysis, expert opinions, and a comparison of
other facilities’ guidelines for autism screening. Steps that occurred to create the
guideline included (a) creating a phenomena of interest for ASD screening in primary
care, (b) reviewing literature to back the creation of a new guideline, (c) analyzing the
literature, (d) interviewing experts, (e) critiquing at least two other guidelines from other
clinics where ASD screening was practiced, (f) working closely with a primary care
clinic’s protocol department to establish rules and needs of the facility for a guideline,
and (g) using all the information gathered to create the guideline.
The burden of disease for children with ASD is high and delayed diagnosis is all
too common in primary care (Augustyn, 2016b). Establishing a quick reference and easy
to understand guideline for providers to follow on how to screen for ASD appropriately
would consider the limited provider and patient face-to-face time. The algorithm would
provide a quick reference of red flags providers must catch during any visit with a child,
especially with well-child checks. The intervention plan for this project was established
by following similar steps from exemplar process improvement projects.
To teach the guideline, two educational seminars were held with all the providers
and staff at the clinic to re-educate as well as provide the new guideline and algorithm for
autism-specific screening. Being an educational clinic, it is common practice to provide
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educational seminars periodically throughout the year. Taking advantage of this format,
one of the pre-existing educational seminar topics focused around screening for ASD--the
focus of this capstone project. The educational programs lasted approximately 60
minutes.
Data Collection Details
To evaluate the success or failure of this project, a chart audit was performed.
Furthermore, due to the evaluative nature of the educational program, the clinic staff
(primary care providers including NPs and all the clinic MAs) were asked to complete a
survey before and after the educational offering. Providers and staff were approached at
the beginning of the educational session and asked to consider being in the study.
Consent forms were distributed (see Appendix B) along with Part 1 of the survey. The
educational program lasted approximately 60 minutes. After the program ended, the
consented participants completed Part 2 of the survey. As seen in Appendix C, Parts 1
and 2 of the survey are very similar other than Part 2 of the survey has some additional
questions about the program itself. Parts 1 and 2 of the survey were not connected to
participants but rather aggregate data were reported and compared. As one might expect,
Part 2 program evaluation data will inform future educational sessions and were also
anonymous in nature. Although no strict qualitative evaluation took place on evaluation
data from Part 2 of the survey, information was collected to inform future program
offerings and was deemed important to the clinic by the outside committee member.
Performing a thorough chart audit of this process improvement project was vital
to measure process improvement outcomes. The chart audit focused on the following
timeframes: pre-educational seminar (three months) and post-educational seminar (six

27
weeks--early Spring 2017). The timeframe accounted for the necessary educational
seminars so all staff could participate at the clinic in early January and EHR update. The
chart audit evaluated all well-child exams from 16 to 30 months (this was the
recommended time frame for when the M-CHAT R and M-CHAT R/F should be
administered).
Chart review data points included whether or not screening was done with both
the general developmental screening, ASQ3 and autism-specific screening, M-CHAT R,
whether a referral for diagnosis was made--“yes” or “no,” and whether a referral for
disability evaluation for ASD was made--“yes” or “no.” This evaluation method solely
focused on assessing if providers screened appropriately and utilized appropriate
documentation. Simple descriptive statistics to describe the number of charts reviewed,
percentage in each age category, and numbers of positive and negative data points for
each variable are reported.
Congruence of Organization’s Strategic
Plan to Project
For completion of this project, a key group of organizations agreed on the
strategic plan to create the project guideline and algorithm: University of Northern
Colorado School of Nursing and three northern Colorado clinics. The clinics provide
care for all patients throughout the lifespan, pediatrics, obstetrics, and geriatrics. They
average an overall patient base of approximately 90,000. They care for Medicare,
Medicaid, private insurance, and self-pay patients. Providers include MDs, Doctors of
Osteopathy (DOs), NPs, and physician assistants (PAs). One of the clinics discussed
above was the intended sight for the study. This clinic also has a MD residency program,
offering an even greater opportunity for provider learning since the facility is a teaching
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environment. The clinic has six NPs, seven MD faculty providers, and 38 first to third
year family practice resident MDs. The latter two organizations contributed to the project
by providing expert opinions and exemplars of similar protocols or guidelines for ASD
screening used at their facilities. An expert in the region on ASD and ASD screening
provided expert opinions from a multidisciplinary approach including developmental
pediatricians, psychologists, therapists, and social work. This facility also provided
exemplars of guidelines utilized in primary care for ASD screening. Lastly, Children’s
Hospital of Colorado’s Developmental and Behavioral Clinic provided hands-on clinical
experience by allowing participation in the diagnosis of ASD from a multidisciplinary
approach. As mentioned, a single primary care clinic was the facility where the initial
need for the guideline was identified. Therefore, the ASD screening guideline and
algorithm for primary care settings was created for this clinic. The University of
Northern Colorado School of Nursing worked closely with the author of the project to
follow all rules and regulations regarding any ethical and legal concerns as well as
guidance and advice. At this time, these were the only organizations involved with the
project.
Timeline of Project Phases
The goal of this project was to follow the timeline below:
Summer 2016—Phenomenon of interest approval
Summer 2016—Literature review and synthesis
Summer 2016—Initial writing of proposal for project completed
Fall 2016—Defense of proposal
Fall 2016—Institutional Review Board (IRB) approval (see Appendix D)
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Early Spring 2017—Educational seminar for all staff
Late Spring 2017—Chart audit as well as provider and staff interviews
Summer 2017—Final evaluation
Summer 2017—Capstone project completion
Summer 2017—University of Northern Colorado capstone project approval
Resources
There was no need for a budget because funds were unnecessary to complete any
component of the project. There was a need for outside personnel to be involved with the
project. The greatest contributor to expert opinion and providing exemplar guidelines
was the Children’s Hospital Developmental and Behavioral Department. This
department agreed to spend four days with the author of the project to educate the author
on (a) ASD, (b) the burden of the disease, (c) screening techniques, (d) multidisciplinary
approach of diagnosis, (e) early intervention details and education, and (f) social work
aspects of the disorder. The Children’s Hospital Developmental and Behavioral
Department also provided exemplar guidelines for ASD screening in the primary care
setting. Other personnel utilized to complete research for the project and to provide
guidance along the way were aware no financial resources would be used and all had
affiliation agreements with the University of Northern Colorado.
Stakeholders
There were many stakeholders for this project. Stakeholders from the University
of Northern Colorado included the School of Nursing, the Graduate School, committee
members of the project, and the author. Other stakeholders included the primary care
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clinic where the study occurred including office managers, program directors, IT, and
EHR support staff.
Strategic Analysis
To perform a strategic analysis for this project, a strengths-weaknessesopportunities-threats (SWOT) exemplar was used. The SWOT tool analyzes all factors
contributing to the successes and/or failures of a process improvement project (United
States Department of Agriculture, Risk Management Agency, 2008). Change can be
challenging, especially in health care. With change comes uncertainty. The reason a
strategic analysis should always be done is to assure the process improvement project
does improve the process, does not negatively affect patients or providers, and assures the
highest quality of care occurs.
Strengths
The strengths of this project included evidence-based, simple-to-use guidelines,
improvement of identification of any concerns or red flags of developmental delays
and/or ASD, provider education, learning opportunities for the author, expert opinion and
literature to support the guideline, thorough evaluation of the process change, and proof
there was a need for this type of project.
Weaknesses
The weaknesses of this project included a limited time frame to perform chart
audits, implementation of a guideline rather than a protocol, and limited high-quality
research (systematic reviews) to support the guideline.
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Opportunities
Opportunities of this project included learning, improved patient care, increased
awareness of developmental milestones, improved early diagnosis and intervention for
ASD, and improved documentation of developmental or lack of developmental
milestones.
Threats
Threats of this project included resistance of providers to practice change, lack of
willingness of stakeholders to participate, limited timeframe of chart audits, difference of
timeframe of the chart audits, and lack of high quality evidence (systematic reviews) to
support the guideline.
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CHAPTER III

EVALUATION PLAN

To accurately measure and evaluate each objective, it was important to address
each objective separately.
Objective One
The goal of the first objective was to compile all the information gathered during
research to create the guideline and algorithm the primary care clinic would utilize for
universal ASD screening. To complete the first objective, it was imperative to work with
the clinic manager, MA, and NP staff to make the guideline and algorithm system was
specific to fit their needs. The goal was to allow primary care providers to have a simple,
quick guideline to appropriately screen all pediatric patients at 18- and 24-month wellchild exams. This objective helped to apply research to practice. Once the guideline was
established, education to the providers and staff occurred--two educational seminars were
provided with a PowerPoint presentation of the basic education regarding ASD, ASD
screening, and the guideline and algorithm . Moreover, paper and electronic copies of the
guideline and algorithm were provided. The goal was to re-educate providers and clinic
staff regarding ASD, red flags, consequences of delayed diagnosis, and the importance of
appropriately identifying and referring any developmental delays. The pre-intervention
education and implementation of the interventions occurred from July 2016 to December
2016.
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Objective Two
The second objective was to work with IT to improve EHR documentation of
ASD screening for the same primary care clinic. This objective occurred in conjunction
with the first objective. The overall goal of the second objective was to enable higher
rates of provider satisfaction by utilizing EHR technology to allow for quicker screening
utilizing a specific designated place to document the screening was performed. By
having EHR ability to document the M-CHAT R, improved overall documentation was
likely to occur.
Objective Three
The third objective was to evaluate the effectiveness of guideline and algorithm
implementation. The overall focus of this objective was to see an improvement in patient
care outcomes and improved provider satisfaction. By fulfilling objectives one and two,
the intent was to have improved documentation of any red flags raised during well-child
exams, overall increase in the awareness of red flags for autism, an increase in the
occurrence of M-CHAT R and general developmental screenings, the documentation of
these screenings on appropriate patients, an increase in referral to behavioral and
developmental specialists and other community resources, and an increase in early
diagnosis and early intervention in diagnosed ASD cases. The secondary focus of this
project was to increase provider and staff satisfaction. Assessing for outcomes with
regard to provider satisfaction, all the clinic staff including providers and MAs were
asked to complete a survey before and after the educational offering. The focus of the
survey evolved around basic ASD and ASD screening knowledge, resources for referrals
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within the community, satisfaction, and ways to improve the educational platform in the
future.
Method of Analysis
To evaluate the success of this scholarly project, it was important to consider what
type of process would be used to analyze the outcomes. The Donabedian model, which
assesses patient care outcomes, was easily applied to this process improvement project
(Voyce, Gouveia, Medinas, Santos, & Ferreira, 2015). This model has three main
components: system factors, process of care, and health outcomes (see Figure 4).

Figure 4. Donabedian model to assess for patient outcomes (TRIAD Study Group, 2010).
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System factors, which include guideline usage, are the components of health care
by which a certain practice is applied to the patient, e.g., a guideline for autism specific
screening in the primary care setting (Voyce et al., 2015). This system factor affects how
autism-specific screening occurs in the primary care setting. The guideline and algorithm
provides a systematic and simple guide on developmental red flags such as no babbling
by nine-months-old (Augustyn, 2016a).
Processes of care is the actual care provided to patients while following the
guideline. For example, if a practitioner who follows the ASD screening guideline and
algorithm observes a 16-month-old not babbling, this would be an appropriate time to
screen for ASD using the M-CHAT R screening tool, which would then further indicate
the next step in care.
The final process of the Donabedian model is health outcomes (Voyce et al.,
2015). When looking at the patient scenario described above, the provider notes a
developmental delay and screens for ASD appropriately (all the while following the ASD
guideline and algorithm), and then decides the patient should be referred to Children’s
Hospital for developmental delay screening and ASD screening. While 16-months-old is
young, the goal of all ASD care is early intervention. By following the guideline and
subsequently identifying a red flag, screening appropriately, and referring, early
intervention will occur for this patient. Also, considering this patient scenario, these
concerns as well as the screening tool would be well documented for any provider who
might see the patient so the highest quality of care could be consistently provided to the
patient. By following the Donabedian model, a thorough method of analysis occurred
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and successes of the process improvement project were addressed to improve patient care
(Voyce et al., 2015).
Summary
All objectives were evaluated to assure objectives were met. To create and
implement an evidence-based guideline and algorithm, the author needed to be well
versed in all the information that came with the subject. Through objective three, patient
care outcomes were evaluated using the Donabedian (2001) model. This model was then
applied to this process improvement project because it focused on patient care outcomes.
The overall focus of all three objectives was to improve patient care outcomes regarding
developmental delay, ASD, and ASD screening by creating a tailored clinical guideline
and algorithm. Improvement in patient care outcomes with this project also included an
increase in overall documentation of or lack of developmental milestones. An
improvement in provider and staff satisfaction was also a focus.
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CHAPTER IV

RESULTS

Theoretical Framework
All necessary preparatory work for this project was completed utilizing the Stetler
(2001) model. By framing this scholarly project with the Stetler model, which allocated a
research utilization model to be applied to practice, all objectives were met. The Stetler
model allows clinicians to incorporate evidence-based research findings into their clinical
practice. Phases I-IV of the Stetler Model were utilized in all the necessary preparatory
work and included objectives one and two. Phases I-V included preparation, validation,
comparative evaluation, decision making, and translation and application (Stetler, 2001).
Phase VI (evaluation) was completed with the third objective of this capstone project.
Overall, using the Stetler model to implement research into practice made the process
improvement project successful. A thorough description of the project’s results is
discussed as follows.
Objectives
Objective One
Objective one revolved around compiling all the information gathered during the
critical research phase, which included Phases I-V of the Stetler (2001) model. At the
compilation of Phase V (translation and application), the final clinical guideline and
algorithm was established (see Appendices E and F). To incorporate phases II-IV and to
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prepare the guideline and algorithm, collaboration with the Children’s Hospital
Developmental and Behavioral Department occurred. To translate and apply the
guideline and algorithm for the fifth phase of the Stetler model, two thorough educational
seminars occurred in January 2017. The educational programs lasted approximately 60
minutes. Paper and electronic copies of the documents were also supplied to all the
clinicians and clinical ancillary staff to provide a quick reference as needed. The overall
goal of objective one was to provide extensive education to all the clinic staff as well as
to incorporate the process improvement intervention of a clinical guideline and algorithm
for ASD screening in primary care. The main aspect of clinician and clinical staff
education was completed with the successful educational seminars.
Objective Two
The focus of objective two was to work with clinical IT to establish an
appropriate EHR documentation resource for the M-CHAT R screening tool. This
objective worked in conjunction with objective one. After numerous emails and inperson conversations with management and clinicians regarding this EHR step, the
objective was fulfilled. During final implementation of objective one, IT created a quick
reference box for clinicians to click when the M-CHAT R was completed at the age
appropriate well-child check. Furthermore, this imperative clinical documentation step
was fulfilled prior to objective one educational seminars. As a result, the educational
session was able to cover the specific location of the charting for MCHAT R within the
existing EMR. The ability to align these objectives in such a manner enhanced the
educational session with real-world application for providers. Unfortunately, IT has not
yet been able to create a quick reference box to report the M-CHAT R score, if the M-
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CHAT R/F was completed, and the score if available. This aspect of clinical
documentation was also imperative to convey. Currently, IT is working to create these
documentation aspects within the EHR. Nonetheless, objective two was fulfilled because
a quick reference click-box was implemented into the EHR to document the M-CHAT R
screening was performed.
Objective Three
Objective three encompassed formal evaluations of objectives one and two--the
critical sixth phase of the Stetler (2001) model. Objective three was broken down into
two main aspects of project evaluation. First, the results of the chart audit preimplementation and post-implementation to evaluate if screening with the M-CHAT R
improved after the educational seminars and implementation of the guideline and
algorithm were presented. Secondly, the clinician and clinical staff’s (i.e., participants)
general knowledge was evaluated during pre-and post-educational seminars to determine
if the education enhanced knowledge.
These two evaluation methods were completed using the following steps. As
previously mentioned, a de-identified chart review of all well-child visits between the
ages of 16 to 30 months occurred to determine the rate of ASD screening three months
prior to the educational intervention. Once these data were collected, an educational
session was provided about and screening for ASD. After the educational program, a
second de-identified chart audit occurred to review the same information six weeks
afterwards. Participants were approached at the beginning of the educational session and
asked to consider participating in the study. Consent forms were distributed along with
part one of the survey (see Appendices B and C). At the end of the educational session,
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the consenting participants completed part two of the survey (see Appendix C). As seen
in the appendices, part one and part two of the survey were similar other than part two of
the survey having some additional questions about the program itself.
Chart audit results. Overall findings of the chart review indicated the M-CHAT
R screening rates as well as the general developmental screening rates improved after the
educational seminar. It is important to note that due to the sample size, basic percentages
were represented as statistically significant for the chart audit data points. Because of the
small sample size, a t-test, chi-square, or nonparametric equivalent would not have been
applicable.
The information provided by the chart audit lent evidentiary support that
increasing provider awareness regarding ASD and ASD screening techniques was valid
and applicable in primary care. There were two main findings in the pre- and post-groups
(see Tables 3 and 4). First, overall screening for basic developmental delay with the
ASQ3 screening questionnaire improved after the educational seminar. Basic
developmental delay was an imperative component of the provided educational seminar.
This was because clinicians must be able to recognize developmental delays at every
well-child check. As mentioned, this was done using the evidence-based ASQ3
screening questionnaire. However, as seen with the chart audit data, basic developmental
delay screening did not always occur. For example, basic developmental delay screening
in the pre-audit was 92.7% and basic developmental delay screening in the post-audit was
93.6%. The post- audit’s improvement in screening was just under 1%. As seen with
this data point, gains helped to substantiate that a simple clinician educational seminar
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could enhance provider knowledge and improve patient care outcomes by using
evidence-based screening methods.

Table 3
Pre-Intervention Chart Audit
ASQ3
Occurrence

M-CHAT R
Occurrence

Referral for
Diagnosis

Referral for
Therapy

Total

Total
Sample
Size
41

38

7

0

2

Percentages

N = 41

n = 38
(92.68%)

n=7
(17.07%)

n=0
(0%)

n=2
(0.04%)

Table 4
Post-Intervention Chart Audit
ASQ3
Occurrence

M-CHAT R
Occurrence

Referral for
Diagnosis

Referral for
Therapy

Total

Total
Sample
Size
31

29

14

0

0

Percentages

N = 31

n = 29
(93.54%)

n = 14
(45.16%)

n=0
(0%)

n=0
(0.0%)

With regard to ASD screening rates using the M-CHAT R, screenings in the preaudit group were approximately 17%; in the post-audit group, screenings jumped to
45.16%. An increase of 28.16% in ASD screenings rates using the M-CHAT R occurred
after the educational session and implementation of the guideline and algorithm. As seen
with the M-CHAT R, screening increases indicated either many clinicians were
previously unaware of the screening tool or there was a general lack of knowledge
regarding screening. As stated by the Rhoades et al. (2007) study, specialized training
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for ASD surveillance is valuable: “We recommend that all physicians receive specialized
training about ASD to improve upon early screening and diagnosis, and then advise
caregivers about empirically supported services” (p. 37). To conclude, basic
developmental delay screening and universal screening for ASD using the M-CHAT R
tool improved after the educational session and the implementation of the guideline and
algorithm.
Two other data points were evaluated in the chart audit: referral for diagnosis and
referral for therapies. These two data points were not found to be statistically significant
in this study. For example, referral for diagnosis remained 0% in the pre- and post-chart
audit groups. Furthermore, referral for therapies decreased slightly from 0.04% in the
pre-audit group to 0% in the post-audit group.
The overall results for referral for diagnosis and referral for therapies were not
surprising. The children within the chart audit timeframe and of the appropriate age
grouping (16 to 30 months) might not have needed referral for therapies or diagnosis due
to receiving a negative screening. It is also conceivable the children in the pre-audit
group who required referral for therapies were identified using the basic developmental
screening prior to the implementation of the educational session and the guideline and
algorithm. This might mean further referral for therapies after implementation was not
necessary. Overall, the process improvement implementation of this project could have
no bearing on these two data points as they might be variable due to the intervention.
Data like these might mean there were no positive screenings within the given timeframe
and/or any positive screenings were caught using the basic developmental screening tool.
One important caveat to this was the referral rates for diagnosis remained zero in the pre-
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audit sample. In other words, the children referred for therapies in the pre-group were
not referred for developmental delay or ASD evaluation they might have needed.
A final component regarding findings from the chart audit was a series of errors
or red flags that were never adequately followed through from the perspective of
documentation. For example, noted speech delays were provided but there was no
mention of further testing or a follow-through plan. First and foremost, any type of
developmental delay must be addressed and have a plan. According to the Council on
Children with Disabilities, Section on Developmental Behavioral Pediatrics, Bright
Futures Steering Committee, and the Medical Home Initiatives for Children with Special
Needs Project Advisory Committee (2006), if any component of a formal developmental
screening is positive, it requires a referral for formal evaluation and a referral for
appropriate age-related therapy--either Child Find or Early Intervention. Furthermore,
any type of speech delay should be referred for a formal audiology evaluation to
determine any degree of hearing loss (Feldman, 2005). Referral for diagnostic evaluation
and disability evaluation and referral to a pediatric audiologist should have taken place
and been documented if a speech delay was noted.
To compound the issue of speech delay, multiple instances of charting noted
global delay on the basic developmental screening tool without an action plan to follow
through. In the instance of global delay, the same actions should have been taken as
mentioned above. These are examples of potential missed opportunities that might
represent poor patient outcomes. “Effective interventions at the earliest age possible may
be able to modify early experiences—effectively altering cortical organization, enhancing
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learning, and potentially improving developmental trajectories” (Bradshaw et al., 2015, p.
778).
Survey results. The results of the surveys were represented in both qualitative
and quantitative values. A major focus of the project was to increase provider and staff
knowledge regarding ASD screening techniques. Therefore, pre- and post-surveys were
conducted to see if knowledge improved with the educational seminar and
implementation of the guideline and algorithm. Survey question one was formatted on a
basic Likert scale of 1--Not confident at all to 5--Very confident and asked the participant
to rate his or her confidence level with screening for ASD. Question three of the survey
was formatted with the same Likert scale as question one but asked the participant to rate
his or her confidence level with identifying an abnormal screening for ASD. Participant
surveys are provided in Appendix C for reference.
To formulate a formal t-test, a series of basic statistical tests for significance using
the variables was conducted (see Tables 5-7). Twenty-three participants were surveyed;
however, one pre-survey and one post-survey were never completed. As a result, the
sample group for the statistical analysis was slightly different as it was decided not to
utilize two participants’ data because of the missing surveys.
When evaluating statistical significance, a t-test provides a hypothesis to
determine whether two independent variables are or are not alike (Stone, 2010):
The independent samples t-test is appropriate whenever the researcher wants to
know whether two population group means are different and when the
observations in each of the groups are independent of the observations in the other
group. (p. 402)
With regard to questions one and three on the pre- and post-surveys, the focus
was to evaluate for any statistical differences between the pre- and post-answers for both
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questions. Survey question one asked the recipient to rate his or her confidence level
with screening for ASD and question three asked the participant to rate his or her
confidence level with identifying an abnormal screening for ASD.

Table 5
Frequencies of Quantitative Data from Pre- and Post-Surveys

N

Question 1 Pre
22

Question 1 Post
22

Question 3 Pre
22

Question 3 Post
22

Median

2.0

4.0

2.5

4.0

Mode

1.0

4.0

3.0

4.0

Range

4.0

3.0

4.0

3.0

Minimum

1.0

2.0

1.0

2.0

Maximum

5.0

5.0

5.0

5.0

Table 6
T-Test Paired Sample Statistics
M

N

SD

Standard Error Mean

Pair 1--QPre 1

2.428

21

1.207

0.263

QPost 1

3.857

21

0.792

0.173

Pair 2--QPre 3

2.381

21

1.160

0.253

QPost 3

3.619

21

0.804

0.175
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Table 7
Paired Sample Test
M

SD

Standard
Error
Mean

95% Confidence
Interval- Lower

95% Confidence
Interval- Upper

t

df

Sig.
(2-tailed)

Pair 1--Q1
pre and post

-1.428

0.978

0.213

-1.873

-0.983

-6.691

20

0.000

Pair 2--Q3
pre and post

-1.238

0.889

0.194

-1.642

-0.833

-6.638

20

0.000

Note. T = The paired T test statistic; df = The degrees of freedom for this test; Sig. (2tailed) = The p-value corresponding to the given test statistic t.

The sig (2-tailed) value of both pairings in Table 7 remained p ≤ 0.05. It could also be
concluded there was a statistical difference between the pre- and post-educational
questions (Stone, 2010). The data indicated the participants gained improved basic
knowledge with ASD screening, which was the focus of this project.
Evaluating Table 8 provided further statistical value of the data collected. Table 8
indicates the t-test correlation and significance derived from the data in Tables 5 through
7. The significance for both pair sets, pre- and post-question one and pre-and postquestion three, was p < 0.05. A significance of p < 0.05 means there is a statistical
difference between the two data sets (Stone, 2010). With regard to the pre- and posteducational session and participants’ basic comfort levels with ASD screening and
abnormal screenings, there was a significant difference between the sample pairs. The
educational seminar and implementation of the guideline and algorithm significantly
increased clinician and clinical staff’s knowledge about ASD screening and further steps
to take with positive screenings. The participants scored an improved average of 1.4
points on question one post-survey and 1.3 points on question three post-survey as
compared to the pre-surveys. Question one represented a 95% confidence interval of -
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1.87390 to -0.98324. Question three represented a confidence interval of -1.64280 to 0.83339. The two confidence intervals measured basic knowledge on screening for ASD
and comfort levels with abnormal screenings of ASD before and after the educational
intervention and implementation of the guideline and algorithm. The gains noted with
both pairs in the confidence intervals represented statistical significance with a p ≤ 0.05
by the two-tailed pair t-test (Stone, 2010). Furthermore, it could be concluded, using a
95% confidence interval to determine the t-test, that the negative values of the confidence
intervals did not change the t-test score as the p ≤ 0.05 remained consistent. In summary,
all the data compiled within Tables 5 through 8 showed the intervention of this project
was statistically significant; there was an improvement in knowledge regarding ASD
screening and further steps to take for abnormal screenings.

Table 8
T-Test Paired Sample Correlations
N

Correlation

Significance

Pair 1--Q1 Pre and Post

21

0.590

0.005

Pair 2--Q3 Pre and Post

21

0.645

0.002

Question two on the survey provided great insight into participant knowledge
regarding the M-CHAT R that should be utilized for universal screening at every 18- and
24-month well-child check (see Table 9). The question asked the participant to write
down the correct answer. Because there was only one correct answer (M-CHAT R), data
were represented as a dichotomous response--either “yes” or “no.” For the data
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represented as statistically significant, the focus remained on “yes” or correct responses
before and after the educational intervention. Participants answering correctly prior to
the educational intervention was 43.5%. After the intervention, participants answering
correctly soared to 69.6%. The data with this question were represented only as simple
percentages because of data limitations. Still, the information indicated basic participant
knowledge regarding the M-CHAT R before and after the intervention improved. This
data also indicated that providing additional education and resources such as the clinical
guideline and algorithm implemented with this project increased clinician and clinical
staff knowledge.

Table 9
Survey Question Two Statistics
N

Pre

Post

Yes

23

10

16

Total Percentage

N = 23

n = 10 (43.5%)

n = 16 (69.6%)

No

23

13

7

Total Percentage

N = 23

n = 13 (56.5%)

n = 7 (30.4%)

The quantitative data represented from the educational intervention of this project
lent evidentiary support that clinicians and clinical staff need more education regarding
ASD and screening techniques. Data acquired also supported the Rhoades et al.’s (2007)
study that stated more education was necessary for clinicians to improve ASD detection.
Improving clinician knowledge regarding ASD and ASD screening was the modifiable
challenge addressed by this study. Knowledge was further enhanced by implementing a
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quick reference guideline and algorithm for ASD screening and further steps to take for
abnormal screenings.
Qualitative data analysis from the participant surveys was performed to provide
information for future program offerings and was requested per the clinical site.
Additionally, it provided high quality insight into the driving factors behind and barriers
to ASD screening. Although there were 23 participants, not all surveys were analyzed
within the results section. To highlight important takeaways from the participants’
surveys, this results section discusses four participants’ surveys.
Participant one completed both pre- and post-educational intervention surveys.
Comfort level with ASD screening and abnormal screenings improved with the
intervention. This participant did know the M-CHAT R was the evidence-based
screening tool to utilize; however, this participant stated “unsure” on further steps to take
if the screening was abnormal, on further referral resources, and on referral resources for
disability evaluation within the community on the pre-survey. After the intervention, the
responses improved significantly. Participant one answered correctly on further steps to
take if the screening was abnormal, on referral resources for evaluation, and on referral
resources for disability evaluation in the community on the post-survey.
Interestingly, participant one’s responses for the top three barriers for ASD
screening changed from the pre- and post-surveys. On the pre-survey this participant
answered “time” as the only response; however, on the post-survey, the participant
answered “time, difficulty with ambiguity of screenings, and unfamiliarity with screening
tools.” One could postulate many reasons for this change. One of the foci of the
educational session was a thorough discussion regarding challenges with the screening
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tools such as variability of responses. Furthermore, education was also provided
regarding research supporting lack of clinician knowledge regarding ASD screening as
seen with the Rhoades et al. (2007) study. This participant highlighted these two factors
as significant barriers to screening after the educational session.
The top three motivators for ASD screening changed slightly in the pre- and postsurveys. For example, the pre-survey stated the following as motivators for ASD
screening: “early diagnosis and treatment and family counseling.” After the intervention,
the survey responses for this question changed: “early diagnosis and intervention, family
support, and diagnosis of other medical problems (e.g., hearing loss).” There are many
potential reasons for the changes in responses. For example, the education provided
might have improved clinician knowledge and appreciation for ASD and ASD screening
since there was an in-depth discussion during the educational session of many other
clinical diagnoses that often occur with ASD such as hearing loss or insomnia.
To conclude, participant one noted the biggest takeaway from the educational
intervention was a review of the local resources within the community for those with
developmental delay and/or ASD. A large component of the educational intervention
focused on educating the participants on the resources within the community such as
Child Find or Early Intervention. As discussed with an in-person interview with Dr.
Robin Nolan, Developmental and Behavioral Pediatrician with The Children’s Hospital,
many clinicians are unaware of the resources within their community and, therefore,
children often do not get referred as necessary (R. Nolan, Personal communication,
August 23, 2016). Participant one mentioned an improvement in the future for this type
of educational intervention would be a presentation from a developmental and behavioral
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pediatrician. Primary care clinicians receive minimal education on neurodevelopmental
disorders (Rhoades et al., 2007). Therefore, it could be concluded that clinicians would
benefit from a specialized training on these disorders (Rhoades et al., 2007).
Participant two’s responses were important to highlight because the survey
information conveyed basic knowledge on ASD screening and referral resources for
abnormalities was lacking for some clinicians. On the pre-educational intervention
survey, the participant answered with “little knowledge.” When reviewing basic comfort
levels on the Likert scale with ASD screening and abnormalities of screenings,
participant two answered “2,” meaning the participant was not comfortable.
Furthermore, the participant was unaware of the M-CHAT R screening tool. The
participant listed “unsure” on further steps to take if the screening was abnormal, on
referral resources for diagnosis, and on referral resources for disability evaluation in the
community. Fortunately, after the educational intervention, comfort levels improved to a
4 on the Likert scale and the responses to the questions regarding specific screening with
the M-CHAT R and referral resources were correct.
Important to highlight with this participant were the top three barriers to
screening, which were answered only on the pre-intervention survey: “busy with learning
everything in residency so I choose to focus on common illnesses, not familiar with
resources, and I don’t see it that often.” The responses to barriers in this survey
highlighted common barriers also noted within literature, which might include but were
not limited to lack of education and vague nature of the symptoms (Augustyn, 2016b).
Furthermore, research indicated ASD is not rare and has increasing prevalence for
approximately 1 in 68 children (Salley, 2016). These data showed that while the
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participant did not see ASD commonly, it is more common than some clinicians might
believe (Ecker, Spooren, & Murphy, 2013): “It is currently estimated that 1% of all
children have ASD, and the condition is more common than pediatric cancer, diabetes,
and AIDS combined” (p. 308). Participant two highlighted common barriers that are
known but also as this participant mentioned, “I don’t see it that often”, is not accurate,
this begs for further inquiry. Autism spectrum disorder is more prevalent and is
increasing in prevalence (Augustyn, 2016a) than formerly believed. The information
provided by participant two indicated the need for educational interventions and a
guideline and algorithm to help clinicians increase early detection and decrease the
prevalence of an ASD delayed diagnosis.
The third participant of the study offered insight into basic clinician awareness of
ASD screening. Additionally, this participant delved into how an educational
intervention and guideline and algorithm helped to enhance the knowledge base to
transform the clinician’s practice to follow evidence-based recommendations. With
regard to basic comfort with ASD screening, the participant scored a 3 on the Likert scale
on the pre-survey; this indicated the participant was neither unconfident nor confident
with ASD screening. On the post-educational interventional survey, the participant
scored a 4, meaning this clinician now felt confident with ASD screening. Furthermore,
in the pre-survey, the participant did not understand how to use the M-CHAT R screening
tool and on the post-survey, this participant acknowledged understanding of the MCHAT R.
With regard to basic knowledge of further steps for an abnormal screening, in the
pre-survey, the participant stated “referral.” While this answer was accurate, critical
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pieces of the referral process were missing; in the post-survey, the participant answered
more accurately and specifically to the question: “follow-up M-CHAT R in one month,
referral to the Children’s Hospital, the local resource, and audiology.” These
comparative survey responses highlighted three vital components that must be addressed.
First, of all 23 participants of the study, not a single participant was aware of the MCHAT R/F screening tool that should be performed if the M-CHAT R indicated a
medium or high risk for ASD. As previously indicated, both the M-CHAT R and MCHAT R/F are feasible, simple to use, accurate, and recommended by the AAP (Dreyer,
2016). This global lack of knowledge regarding the M-CHAT R/F highlighted the true
lack of clinician knowledge regarding ASD and ASD screening in primary care (Rhoades
et al., 2007).
A formal and comprehensive audiology screening performed by a pediatric
audiologist is recommended if the M-CHAT R/F indicates an increased risk of ASD.
This recommendation comes directly from the AAP. Harlor and Bower (2009) found the
following:
Developmental abnormalities, level of functioning, and behavioral problems (ie,
autism/developmental delay) may preclude accurate results on routine
audiometric screening and testing. In this situation, referral to an
otorhinolaryngologist and a pediatric audiologist who has the necessary
equipment and expertise to test infants and young children should be made. (p.
1252)
As all 23 of the pre-educational intervention surveys indicated, an audiology
referral was never included as a potential follow-up step if the M-CHAT R was
abnormal. This, however, did change in the post-surveys as the third participant’s answer
indicated. This was an important piece taught while educating the participants on the
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guideline and algorithm created for the clinic as part of the overall intervention of this
project.
Last, participant three’s answers in the pre-survey further showed an overall lack
of knowledge regarding specific referral resources. For example, the pre-survey response
for referral resources for disability evaluation was occupational therapy and physical
therapy. As stated previously, this answer was correct but was missing important
components. The correct answer was Child Find or Early Intervention based on the
child’s age. These resources then determined what therapies the child qualified for based
on his or her level of disability.
As stated previously with regard to the question on further steps to take if an ASD
screening was abnormal, there was global confusion among all the participants on what
resource to utilize for an actual evaluation and diagnosis of developmental delay and/or
ASD. As participant three pointed out, “referral” was appropriate but the question was
consistent across the board in the pre-surveys: “referral” where?
Evaluation for ASD should include a comprehensive assessment, preferably by an
interdisciplinary team. The evaluation aims to definitely diagnose ASD, exclude
conditions that mimic ASD, identify co-morbid conditions, and determine the
child’s level of functioning. (Sanchack & Thomas, 2016, p. 972)
The statement from Sanchack and Thomas (2016) alluded to the importance of a
collaborative approach with neurodevelopmental disorders. This means evaluations
should not come solely from psychiatry or neurology. The team approach should include
but not be limited to developmental and behavioral pediatrician, psychiatry, neurology,
psychology, and speech pathology. The interdisciplinary approach for evaluation and
management of neurodevelopmental disorders like ASD is the approach utilized by
Children’s Hospitals across the nation. For this project, the educational session informed
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clinicians that the local Children’s Hospital was the recommended resource for
developmental delay and/or ASD evaluation and was also represented in the guideline
and algorithm.
The fourth and final survey discussed is participant four. Two components must
be addressed with this survey. First and foremost, the participant gave one response for
the question that asked for the top three barriers for screening for ASD on the postintervention survey: “lack of experience.” Second, in the post-interventional survey
response for discussing the most useful part of the educational session, participant four
answered, “Shed light on this subject that is often neglected.” These responses offered
clinician-guided evidence that there is a lack of experience regarding clinician training
for ASD and, as a result, this subject could be neglected in primary care. “Primary care
physicians report a lack of self-perceived competency, a desire for education, and a need
for improvement in primary care for children with autism. Physician education is needed
to improve primary care for children with autism” (Golnik, Ireland, & Borowsky, 2009,
p. 996).
Participant data from the surveys both before and after the educational
intervention provided valuable insight and suggestions for steps to take in the future to
improve ASD screening and have a more thorough understanding of the many resources
available to those at risk for ASD. For this study, it could be concluded the educational
seminar, clinical guideline, and algorithm succeeded in increasing participant knowledge
regarding ASD screening. By doing this, the modifiable challenge of lack of clinician
knowledge was tackled head on. Another goal of this study was to see an increase in
ASD screening with the M-CHAT R. This goal was achieved and was represented with
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the chart audit data. Delayed diagnosis is the true concern with regard to ASD screening;
however, this was not the focus of this capstone project. By achieving the two goals
mentioned above, the hope is over time ASD delayed diagnoses will decrease for the
participants in this study.
Overall, basic themes derived from the participant surveys represented the need
for continued provider education regarding childhood development and
neurodevelopmental disorders such as ASD. Across the board, participants reported
improvement of knowledge regarding ASD, ASD screening, and further interventions for
abnormal screenings. Participants also reported lack of time, lack of knowledge, and
confusion with referral resources as further barriers to screening and intervention for
ASD. The qualitative data acquired from the pre- and post-participant surveys lent
support to the purpose of this scholarly project. By providing a clinical guideline and
algorithm to enable appropriate screening for developmental delay and universal ASD
screening, participants were provided the necessary information to combat these barriers.
Furthermore, by implementing an educational platform to review the guideline and
algorithm, participants reported improved knowledge regarding ASD and ASD screening.
The myriad of confusion with regard to referral resources for developmental delay and
ASD was a major theme noted throughout the participant surveys. Fortunately, a
thorough discussion of the guideline and algorithm detailed the appropriate steps to take
if developmental delay and/or risk for ASD was noted on screenings and/or clinical
exams.
Important findings from the participant surveys were vast. The most important
takeaway was improvement in participant knowledge after the intervention, which lent
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evidentiary support to continued provider education and tailoring of a clinical guideline
and algorithm to specific clinical sites. By doing so, confusion regarding referral
resources would be addressed. Another important takeaway was provider confusion
regarding referral resources. Lastly, the qualitative data derived from the participant
surveys indicated a theme of limited knowledge regarding ASD and ASD screening in
primary care. As stated previously, it is also important to note common themes in
barriers to screening such as lack of provider time and lack of knowledge regarding ASD.
Key Facilitators
Key facilitators for the three objectives of this project were vast. First and
foremost, Dr. Hessler, Dr. Dunemn, and Mitzi McGarr, FNP were the main facilitators
throughout the project as they comprised the project committee. Dr. Hessler was
instrumental to this project. She enabled a constant lending hand to the researcher and
played a major role in all three objectives. Dr. Dunemn offered guidance and insight,
especially with the data evaluation required during the third objective. Mitzi McGarr,
FNP was the main point of contact at the implementation site and consistently offered
clinical expertise to the researcher. The project committee played the largest role in
facilitating the entirety of this project.
The implementation site was also instrumental to this capstone. The site’s
openness and willingness to allow the researcher to tailor a clinical guideline and
algorithm for ASD screening to their practice was unparalleled. Furthermore, the site
allocating time for the researcher to hold the educational seminar twice to achieve the
highest number of participants possible was invaluable. Leadership associated with the
clinical site offered vital clinical insight and a vast pool of knowledge regarding specific
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concerns and barriers that were modifiable to the project’s success. All the staff of the
clinical site were imperative to the project’s success as they were open to and excited
about the project.
One of the largest key facilitators of this project was the consulting developmental
and behavioral pediatrician from the Children’s Hospital. Her expertise in the field and
clinical advice were impressive. Her clinical guidance with the guideline, algorithm, and
educational seminar played a key role in ensuring components were evidence-based and
applicable to the project. Success of the project was due in part to her expertise.
By consistently applying the Stetler (2001) model, all clinical expertise provided
was appropriately compiled and utilized in the first objective of the project. That being
said, the Stetler model was another important key facilitator to the project’s success. By
following all key six phases of the model, research was implemented into clinical practice
and then was further evaluated in the third objective of the project.
The clinical site’s IT played the largest role in the second objective of the project.
With the lending hand of IT, the EHR documentation change occurred without major
issues. All communication was done through Mitzi McGarr, FNP and the clinical site’s
leadership to assure this process improvement changed prior to the educational
intervention. This change allowed for a simple-to-use reference to document the MCHAT R was performed.
The final key facilitator to this capstone was the IT platform to acquire all the
research, literature review resources, and capstone pertinent communication. By having a
personal IT platform available, the researcher could consistently research and update the

59
project. All steps toward moving forward with the many aspects of a scholarly project
were made possible by the researcher’s personal IT platform.
Key Barriers
Fortunately, this scholarly project had minimal barriers. The main barriers were
willingness to participate in the surveys and applying the education, algorithm, and
guideline to clinical practice. Multiple surveys were returned with very minimal input on
either the pre- or post-surveys, thus yielding minimal statistically significant data.
Surveys can be cumbersome so this barrier was to be anticipated when utilizing
participant surveying as a method of data collection.
The caveat to this, however, was participant utilization of intervention of this
project, specifically participants screening for ASD using the algorithm and guideline and
using the education provided to them to enhance their knowledge of ASD. This was a
barrier because clinician autonomy is vital, and with a guideline there is always going to
be the concern that certain clinicians may not see the importance of the research causing
the intervention to go unutilized. Lack of clinician willingness to respond is another
potentially anticipated barrier to this type of project.
Another difficult barrier to the success of this project was limited clinician time.
Unfortunately, it is difficult to combat this barrier directly; however, by increasing
provider education, there was hope clinician time would be enhanced because of quicker
recognition of red flags and/or risk factors. Also, clinician time could be enhanced by
using a screening tool like the M-CHAT R. The challenge to this, however, was ensuring
the screening was completed in a timely manner. This barrier was also addressed hands
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on by providing extensive education to the clinical staff as they play a key role in
ensuring each clinician’s day runs smoothly.
The final barrier to address with this project was a true lack of resources within
the community for those with developmental delay and/or ASD. Although Child Find
and Early Intervention were available and were eager to help all the children within the
community, the number of therapists to provide services is limited. This meant children
might not be able to achieve the desirable amount of therapy to move in a positive
trajectory because there were not enough resources. This could not be addressed with
this project as the focus remained on screening for ASD in primary care; however,
extensive discussions occurred with Child Find regarding this concern. The researcher
was adequately informed that the best course of action was to refer every patient with
suspicion early even if resources were lacking. The goal, hopefully, was to see an
increased need and therefore an increased demand for resources. By having an increased
demand, increased resources would hopefully be granted.
A further barrier was the challenge presented to clinicians and clinical staff
regarding confusion on the referral resources. This barrier was also addressed directly
with this project by use of the education session and algorithm. All evidence-based and
appropriate referral resources were provided to all clinical staff including the necessary
paperwork, names, and appropriate contact information.
Unintended Consequences
Unintended consequences of this scholarly project could be perceived as both
negative and positive. With regard to the chart audit, many red flags were raised and
addressed with leadership of the clinic. Chart audit documentation findings were not an
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intent of the study but required further follow-up as some could be missed opportunities
and negatively affected patient care. The consequence of this was positive because it
could lead to improved patient outcomes. However, this might also be a negative
consequence because it could be a challenge to accept flaws in clinical care.
Second, the discovery that even the basic developmental screening using the
evidence based ASQ3 tool was not being consistently performed on all age appropriate
well-child exams was a consequence. Moving forward, the clinical staff should ensure
that parents have the screening tool completed before the clinician enters the patient’s
room. This would facilitate the completion of paperwork. Furthermore, there was
discussion within the clinical site to have the clinical staff input the results directly into
the EHR to ease provider use and enhance provider patient time. These changes were
positive consequences of the scholarly project.
When reviewing the participants’ survey results, it was enlightening to see many
clinicians were unaware of appropriate ASD screening and further steps to take if
screening was positive. This was both a positive and negative consequence. First and
foremost, the data supported this scholarly project’s purpose to provide education and
tailor a guideline and algorithm for ASD screening in primary care. Most certainly, this
was a positive consequence. However, this could also be negative because it validated
limited clinician knowledge even in current practice. The data could infer a direct
correlation between lack of physician knowledge and delayed diagnosis of ASD, thus
contributing to poor patient outcomes.
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Summary
Using the comprehensive Stetler (2001) model, the first objective was achieved
by creating a tailored clinical guideline and algorithm for the implementation site.
Objective one entailed compiling all the evidence-based data including expert opinion for
the Children’s Hospital to create the guideline and algorithm. Second, the educational
seminar was successfully completed with 23 consenting participants. The 60-minute
educational sessions took place in January 2015 without complication. The goal was to
provide the educational materials to enhance participant knowledge regarding
developmental delay, ASD, and ASD screening.
The second objective was completed in conjunction but prior to the educational
sessions in objective one. Information technology was able to create a quick reference
box for clinicians to click when the M-CHAT R was completed within the age
appropriate well-child check. Objective two allocated improved clinician charting with a
simple-to-use text box that stated the M-CHAT R was completed. Completion of this
objective occurred after numerous emails and in-person conversations with management
and clinicians regarding this EHR step.
The third and final objective was the formal evaluation of objectives one and two.
Copious data acquired from both the chart audit and participant pre- and post-surveys
supported the overall success of this project. Major findings indicated an increase in both
basic developmental screening and M-CHAT R screening after the implementation of the
education, guideline, and algorithm. Enhanced participant knowledge was appreciated
through the use a t-test, which yielded a p ≤ 0.05. A t-test with this statistical
significance offered support that the educational intervention was successful as it
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improved participant knowledge. Last, participant qualitative input was vastly
appreciated, offered guidance for future educational session offerings, and allowed for
interesting insight into basic clinician knowledge regarding ASD and screening for ASD.
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CHAPTER V

RECOMMENDATIONS AND IMPLICATIONS

With the completion of the three objectives, many recommendations and
implications arose with this process-improvement project. The most important net result
from this project was the need for more education in primary care regarding
developmental delay, ASD, and potentially other types of neurodevelopmental disorders.
As indicated with objective one with all the data compilation, literature has shown more
education is necessary for primary care providers. Data acquired with this project from
objective three unequivocally showed the benefit that could be drawn from increasing
clinician education. An ASD screening educational platform, clinical guideline, and
algorithm were the interventions of this project. By implementing these critical steps to
clinician practice, ASD and basic ASD screening knowledge were enhanced. As shown
by the examples provided with the qualitative data from the participant surveys, general
knowledge was lacking, which meant this area of clinical practice could be neglected.
Furthermore, as indicated by the survey quantitative data from the Likert scale questions,
having an educational intervention increased participant knowledge and comfort with
ASD screening.
A recommendation that could be assumed with this result was to provide
consistent education to primary care clinicians and clinical staff regarding ASD, ASD
screening, and any changes recommended for ASD care. An implication of this
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recommendation from this project would improve ASD awareness, ASD screening, and
overall screening for developmental delay. The overall goal would be to see a decrease
in delayed diagnosis of ASD. Furthermore, this recommendation would encourage
prompt referral for early intervention, which in turn would improve the child’s lifelong
developmental trajectory.
As indicated with this capstone project, ASD can be challenging to identify in
primary care. According to Daniels et al. (2014),
A recent systematic review of studies examining age at ASD diagnosis identified
myriad factors associated with delayed diagnosis at the child, family, and
community levels, including greater symptom severity, lower socioeconomic
status, racial/ethnic minority status, low levels of caregiver awareness of the early
signs of autism, living in resource-poor settings, and visiting greater numbers of
clinicians before diagnosis. (p. 141)
Myriad dilemmas contributing to delayed diagnosis of ASD were addressed with
this scholarly project by tailoring a clinical guideline and algorithm for a specific clinic to
universally screen for ASD every well-child check at 18 and 24 months using the MCHAT R screening tool. The M-CHAT R did have setbacks. According to Sanchack
and Thomas (2016), “When used alone, it has poor positive predictive value and a highfalse positive rate” (p. 975). To address this, Sanchack and Thomas created the
secondary screening tool (the M-CHAT R/F) to enhance the reliability of both screening
measures. A major piece of the clinical guideline and algorithm addressed utilizing both
the M-CHAT R and the M-CHAT R/F if the M-CHAT R was high risk for ASD.
A major implication from the project regarding the M-CHAT R and M-CHAT
R/F was participants universally stated not having knowledge of the M-CHAT R/F
secondary screening tool. Furthermore, the large lack of clinician awareness of the MCHAT R screening tool was brought to light with the results of this project.
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A strong recommendation from this scholarly project was that universal screening
for ASD using the M-CHAT R and the M-CHAT R/F, while currently an “I”
recommendation from the USPSTF (Siu et al., 2016), was appropriate and might improve
patient outcomes. Primary care clinicians might lack the expertise to consistently stay
ahead of clinical red flags and risk factors for ASD alone (Rhoades et al., 2007). With
this project, there was a general lack of knowledge regarding ASD and ASD screening
techniques in the participants. The survey results did show an increase in knowledge
from pre-survey to post-survey but the actual increase in knowledge, retention of that
knowledge, and any action in the providers was not able to be determined. That being
said, universal screening for ASD at every well-child check at 18 and 24 months offers
the best surveillance for ASD early, thereby improving developmental outcomes and
quality of life.
The project timeline did not allow for long-term data collection to occur. Due to
this timeline, it was plausible chart audit data did not facilitate a change in referral status
for those children at high risk of ASD. Post-intervention chart audits yielded a
statistically significant increase in screening for ASD using the M-CHAT R but there was
no increase in referrals for diagnostic evaluation or for disability evaluations using
community resources. As discussed previously, the reason for this was not directly
related to universal screening. The largest factor was the children within the chart audit
timeframe did not test positive and might indeed not have ASD or further developmental
delay; however, this was not a negative per se.
An implication and a recommendation from this outcome offer strong need for
further research. With regard to this capstone alone, further research could be conducted
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over a longer timeframe to evaluate if the interventions, the educational sessions,
guideline, and algorithm did in fact improve screening and increase early detection and
prompt referrals. It happened to be a lucky coincidence that the implementation clinic
was also a primary care MD residency. At this specific location, the residents were also
required to complete a type of capstone process-improvement project. The goal of the
researcher was to offer guidance and to have a resident or group of residents adopt the
model and framework of this scholarly project and research further using the same
clinical guideline and algorithm.
Discussed previously was the general concern among the medical community
regarding universal screening for ASD because of the recent USPSTF recommendations
(Siu et al., 2016). While this project alone did not address improved patient outcomes
related to universal screening (meaning there was no statistical change in referral rates
given the data), this did not mean the USPSTF recommendation should stay firm.
“However, there are no randomized clinical trials assessing the effectiveness of screening
for ASD in children three years or younger based on long term outcomes” (Sanchack &
Thomas, 2016, p. 974). More long-term empirical research must be conducted to further
evaluate universal ASD screening and improve patient outcomes. The strong need for
further research was another major implication and outcome of this scholarly project.
Another takeaway from this project was a further need for improvement in
documentation regarding developmental screening, developmental delay, ASD, and ASD
screening. As discussed in the results section, red flags were noted throughout the chart
audit. Some of the red flags were minimal, i.e., no documentation of the developmental
screening scoring. This might create future legal woes for the clinician. Further
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recommendations and implications of this unintended finding indicated a need for
continual quality improvement chart auditing with regard to well-child exams
specifically. Based on Gregory, Van Horn, and Kaprielian (2008), chart audits within a
practice care setting are valuable: “A chart audit is simply a tool physicians can use to
check their own performance, determine how they're doing and identify areas where they
might improve” (p. A3).
Interestingly, an unintended outcome of this project lent support to enhancing
provider knowledge and raising awareness regarding childhood development,
developmental delay, and the potential need for referrals for appropriate disability
evaluation. “Primary care physicians are not very confident in their abilities to identify
children who might be eligible for special education services” (Hastings, Lumeng, &
Clark, 2014, p. 170). As discussed previously, disability evaluation comes from local
community resources, Child Find, or Early Intervention. It became clear through the
participant surveys as well as with the chart audit, even basic child developmental delays
as well as critically important developmental delays varied. As stated previously,
according to the Council on Children with Disabilities, Section on Developmental
Behavioral Pediatrics, Bright Futures Steering Committee, and the Medical Home
Initiatives for Children with Special Needs Project Advisory Committee (2006), any
amount of developmental delay noted on the general developmental screenings warranted
referral for disability services and potentially for further diagnostic evaluation.
Moreover, speech delays also required further referral for a complete audiology workup
(Feldman, 2005). A recommendation and implication to follow this finding also brought
up the importance of continued education for providers regarding developmental delay,
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ASD, and other types of neurodevelopmental disorders. Addressing this outcome could
also be fulfilled with a clinical guideline and algorithm.
Last, as indicated with the participant survey results, confusion was abundant
regarding the numerous referral resources for children with developmental delay, ASD,
and/or other types of neurodevelopmental disorders. As highlighted with an in-person
interview with Dr. Robin Nolan, Developmental and Behavioral Pediatrician with the
Children’s Hospital, many clinicians were unaware of the resources within their
community. Therefore, children often did not get referred as necessary (R. Nolan,
Personal communication, August 23, 2016). Further recommendations and implications
of this finding unequivocally advocated for a tailor-made clinical guideline and algorithm
for clinics and resources within their specific areas. This recommendation was precisely
this scholarly project’s focus—tailored clinical practice steps. By implementing this
critical process-improvement, intervention project, earlier prompt referrals and improved
patient outcomes are expected.
Project Limitations
However limited, data from this study still offered statistical significance.
Limitations are expected with a survey-type study design. Limitations within this project
included but were not limited to restricted geographical location of one clinic, factors in
patient demographics (implementation facility primarily caring for a Medicaid type
population), and a limited timeframe for chart audits and clinical practice changes. These
limitations opened an important discussion regarding ASD prevalence, screening
prevalence, and ASD care. Obviously, collected data representing one small geographic
area are not representative of a large population sample. Furthermore, data collected
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within the chart audit were limited and might not bode the clinical changes desired from
the intervention due to time constraints.
Despite these limitations, statistically important clinical outcomes were addressed
and process improvement did occur. The project helped identify a need for increasing
clinician knowledge regarding ASD and ASD screening, the importance of universal
screening, and having the tools, such as a clinical guideline and algorithm, to be
successful with screening. The numerous outcomes mentioned and recommendations
and implications of such outcomes are clinically important and could improve patient
care outcomes and quality of life.
Future of the Project
The subsequent multitudinous recommendations and implications of the capstone
project should be expanded mainly because a true need was identified within the
background work and literature and a statistically significant intervention was
implemented. Taken together, these facts indicated this work should not be reduced or
phased out but indeed expanded upon. As stated, more research needs to be done in the
field of ASD and ASD screening (Sanchack & Thomas, 2016). Consistent, specialized
training should be given to primary care providers on developmental delay, ASD, and
other neurodevelopmental disorders to enable earlier identification and prompt action
(Rhoades et al., 2007). Findings of this project strongly implied an educational
intervention, clinical guideline, and algorithm increased clinician knowledge regarding
ASD and ASD screening and improved screening rates. This being said, improved
developmental trajectories in children (Bradshaw et al., 2015) could be anticipated; thus,
this project should be expanded.
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Further evaluations that might need to be included with this type of project
outside this Doctor of Nursing Practice (DNP) scholarly project are limited. To expand
this project, the same theoretical framework and objectives could be utilized but
measured over a longer timeframe to evaluate for any care changes. For example,
another study could be conducted on an interval basis to see if screening improved after
the initial post-educational intervention but then subsequently dropped after a period of
time.
Future phases of this project could be completed by any clinician interested in
expanding the framework of this project. As stated previously, the goal of this researcher
was to have this project subsequently adopted by one of the clinic’s MD residents to
evaluate the intervention over a longer term, being they stayed with the facility for three
years. However, future DNPs could also adopt this project, tailor the clinical guideline
and algorithm to a different clinic, and implement the changes using the same educational
intervention to assess if the findings were unique at different institutions. If this were
done, data might be interesting because data from different institutions with different
educational levels could render new insights. Another aspect that might produce even
further intriguing data would be whether clinicians over a long period of practice time
experienced less clinical knowledge on developmental delay, ASD, and other types of
neurodevelopmental disorders. Furthermore, was there more of a “complacency” with
expert clinicians versus novice clinicians? All of this validated further expansion of this
project.
Personnel necessary for any future steps would be consistent with the framework
of this specific project. For example, if a DNP student was to adopt this project’s
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framework, another committee would be necessary. Any implementing facility would
require leadership and clinician approval. With objective two, work would be necessary
to coordinate with IT at the implementing facility. Coordination with the appropriate
community resources such as Child Find and Early Intervention would also need to occur
to tailor the clinical guideline and algorithm to a specific location. Furthermore,
coordination and collaboration with the Children’s Hospital was an integral component of
this project. Further multi-disciplinary approach would also be necessary for future
success.
As the main researcher for this project, much interest has been generated from
other facilities regarding the successful project findings and further implementation of the
intervention to other clinics. That being said, this project could likely be applied to other
settings. Reasoning for this was two-fold. First, as stated frequently throughout the
capstone, general lack of clinician knowledge regarding the subject area was rampant.
Second, there was a need for a tailored clinical guideline and algorithm to address ASD
and ASD screening. A major reason for this was because of the confusion amongst the
clinical community regarding current USPSTF findings (Siu et al., 2016). With a known
major clinical gap in care regarding ASD identification, otherwise known as ASD
delayed diagnosis (Barton et al., 2012), universal screening is key to prompt
identification. Augmenting confusion is unawareness of further steps to take if screening
is abnormal as seen from the data of this project. Because of this, the intervention of this
project with the clinical guideline and algorithm was imperative to improving pediatric
preventive clinical care.
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Personal Attainment of Leadership Goals
The concept of a DNP scholarly project surrounds many aspects of DNP clinical
care, research, leadership, evidence-based practice, and process improvement strategies.
According to the American Association of Colleges of Nursing (AACN; 2015),
leadership is an integral component to a DNP scholarly project and to DNP clinical care:
“Practice includes leadership, advancing the quality of nursing care and the profession of
nursing through policy evaluation, development, and advocacy, and the creation and
maintenance of healthy work environments” (p. 3). Through the many processes of this
scholarly project, leadership goals of the researcher were successfully attained.
First and foremost, innovative thinking and strategies were utilized by the
researcher to conceptualize the initial plan for the project. There were many challenges
throughout its implementation, especially with regard to how to evaluate this type of
process improvement project. The researcher had to adapt care delivery methods to tailor
the educational platform, clinical guideline, and algorithm to the implementation site.
Patient advocacy remained at the forefront of the project and was a large piece of
collaborative effort with Child Find, Early Intervention, the Children’s Hospital, and the
implementation facility.
The transferal of evidence-based practice to actual clinical practice was simplified
by use of the Stetler (2001) model. The Donabedian model (TRIAD Study Group, 2010)
was utilized to assess patient outcomes in relation to the project. By following theoretical
frameworks to guide the project’s purpose, literature evaluation, implementation, and
evaluation, the researcher navigated the processes of the DNP project smoothly.
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Institutional Review Board processes with the university /required extensive
collaboration and effort from the researcher and project committee members. By
following the processes of IRB and collaborating with others, leadership and persistence
were continually noted. Navigating these processes strengthened the researcher’s
leadership skills.
The overall purpose of a DNP scholarly project is to demonstrate clinical
scholarship and leadership (AACN, 2015). With the educational sessions, the researcher
had to command leadership from the participants of the study. Without this, the
intervention would not have been successful. Furthermore, for the researcher
specifically, the educational sessions were intimidating. As a DNP student, attentiveness
and respect from the participants were necessary. This encouraged the researcher to
overcome public speaking fears and maintain a high-level of confidence throughout the
entire project, especially during the educational sessions. This allowed the researcher to
grow tremendously as a future leader.
Summary
With the data acquired through a compilation of the three objectives of this DNP
project, project successes were abundant. As seen throughout Chapters IV and V of this
scholarly project, ASD and ASD screening awareness were enhanced, provider
satisfaction with ASD was addressed, and ASD specific screening was improved. These
were the major accomplishments of this project; however, there were also minor
takeaways, all of which were thoroughly discussed in Chapters IV and five. A clinical
guideline and algorithm regarding universal ASD screening in primary care were
instrumental to the educational intervention of this project. By having these resources,
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provider satisfaction was also further addressed by having a simplified process to follow.
Taken from the successes of this project were further clinical recommendations to be
considered. Furthermore, because of the project’s success, research and theoretical
makeup ascertained from this project should be expanded.
Through this project, it was clear universal screening for ASD using the M-CHAT
R at every 18- and 24-month well-child exam was vital, which was supported by copious
literature as well as data acquired with the intervention of this project. By implementing
universal screening for ASD, improved patient outcomes will occur because of early
recognition and prompt referral. This will combat the myriad barriers to identifying
ASD. From a clinician standpoint, having a clear-cut clinical guideline and algorithm,
ASD screening can be simplified, which in turn will enhance provider satisfaction. All of
these factors will combat delayed diagnosis of ASD and improve the quality of life off
children and their families.
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APPENDIX A
MODIFIED CHECKLIST FOR AUTISM IN TODDLERS,
REVISED WITH FOLLOW-UP
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www.mchatscreen.com or
contact Diana Robins at
DianaLRobins@gmail.co
m Permissions for Use of
the M-CHAT-R/FTM
The Modified Checklist for Autism in Toddlers, Revised with FollowUp (M-CHAT-R/F; Robins, Fein, & Barton, 2009) is a 2-stage parentreport screening tool to assess risk for Autism Spectrum Disorder
(ASD). The M-CHAT-R/F is available for free download for clinical,
research, and educational purposes. Download of the M-CHAT-R/F and
related material is authorized from www.mchatscreen.com.
The M-CHAT-R/F is a copyrighted instrument, and use of the MCHAT-R/F must follow these guidelines:
(1) Reprints/reproductions of the M-CHAT-R must include the
copyright at the bottom ( 2009 Robins, Fein, & Barton). No
modifications can be made to items, instructions, or item order
without permission from the authors.
(2) The M-CHAT-R must be used in its entirety. Evidence indicates
that any subsets of items do not demonstrate adequate
psychometric properties.
(3) Parties interested in reproducing the M-CHAT-R/F in print (e.g.,
a book or journal article) or electronically for use by others (e.g.,
as part of digital medical record or other software packages) must
contact Diana Robins to request permission
(DianaLRobins@gmail.com).
(4) If you are part of a medical practice, and you want to incorporate
the first stage M-CHAT-R questions into your own practice’s
electronic medical record (EMR), you are welcome to do so.
However, if you ever want to distribute your EMR page outside
of your practice, please contact Diana Robins to request a
licensing agreement.
Instructions for Use
The M-CHAT-R can be administered and scored as part of a well-child
care visit, and also can be used by specialists or other professionals to
assess risk for ASD. The primary goal of the M-CHAT-R is to
maximize sensitivity, meaning to detect as many cases of ASD as
possible. Therefore, there is a high false positive rate, meaning that not
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all children who score at risk will be diagnosed with ASD. To address
this, we have developed the Follow-Up questions (M-CHAT-R/F).
Users should be aware that even with the Follow-Up, a significant
number of the children who screen positive on the M-CHAT-R will not
be diagnosed with ASD; however, these children are at high risk for
other developmental disorders or delays, and therefore, evaluation is
warranted for any child who screens positive. The M-CHAT-R can be
scored in less than two minutes. Scoring instructions can be downloaded
from http://www.mchatscreen.com. Associated documents will be
available for download as well.
Scoring Algorithm
For all items except 2, 5, and 12, the response “NO” indicates ASD risk;
for items 2, 5, and 12, “YES” indicates ASD risk. The following
algorithm maximizes psychometric properties of the M-CHAT-R:
LOW-RISK:
Total Score is 0-2; if child is younger than 24 months,
screen again after second birthday. No further action
required unless surveillance indicates risk for ASD.
MEDIUM-RISK: Total Score is 3-7; Administer the Follow-Up
(second stage of M-CHAT-R/F) to get additional
information about at-risk responses. If M-CHAT-R/F
score remains at 2 or higher, the child has screened
positive. Action required: refer child for diagnostic
evaluation and eligibility evaluation for early
intervention. If score on Follow-Up is 0-1, child has
screened negative. No further action required unless
surveillance indicates risk for ASD. Child should be
rescreened at future well-child visits.
HIGH-RISK:
Total Score is 8-20; It is acceptable to bypass the
Follow-Up and refer immediately for diagnostic
evaluation and eligibility evaluation for early
intervention.
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Childʼs name
Age

Relationship to child

Date
M-CHAT-RTM (Modified Checklist for Autism in Toddlers Revised)
Please answer these questions about your child. Keep in mind how your child usually behaves.
If you have seen your child do the behavior a few times, but he or she does not usually do it,
then please answer no. Please circle yes or no for every question. Thank you very much.
1.
If you point at something across the room, does your child look at it? Yes
No
2.
Have you ever wondered if your child might be deaf? Yes No
3.
Does your child play pretend or make-believe? (For example, pretend to
drink from an empty cup, pretend to talk on the phone, or pretend to feed a
doll or stuffed animal?) Yes No
4.
Does your child like climbing things? (For example, furniture, playground,
equipment, or stairs) Yes No
5.
Does your child make unusual finger movements near his or her eyes?
(Example, does your child wiggle his or her fingers close to his or her
eyes?) Yes No
6.
Does your child point with one finger to ask for something or to get help?
(Example, pointing to a snack or toy that is out of reach) Yes No
7.
Does your child point with one finger to show you something interesting?
(For example, pointing to an airplane in the sky or a big truck in the road)
Yes No
8.
Is your child interested in other children? (For example, does your child
watch other children, smile at them, or go to them?) Yes No
9.
Does your child show you things by bringing them to you or holding them
up for you to see not to get help, but just to share? (For example, showing
you a flower, a stuffed animal, or a toy truck) Yes No
10. Does your child respond when you call his or her name? (For example, does
he or she look up, talk or babble, or stop what he or she is doing when you
call his or her name?) Yes No
11. When you smile at your child, does he or she smile back at you? Yes No
12. Does your child get upset by everyday noises? (For example, does your
child scream or cry to noises such as a vacuum cleaner or loud music?) Yes
No
13. Does your child walk? Yes No
14. Does your child look you in the eye when you’re talking to him or her,
playing with him or her, or dressing him or her? Yes No
15. Does your child try to copy what you do? (For example, wave bye-bye,
clap, or make a funny noise when you do) Yes No
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16.
17.
18.

19.

20.

If you turn your head to look at something, does your child look around to
see what you are looking at? Yes No
Does your child try to get you to watch him or her? (For example, does your
child look at you for praise, or say “look” or “watch me”?) Yes No
Does your child understand when you tell him or her to do something? (For
example, if you don’t point, can your child understand “put the book on the
chair” or “bring me the blanket”?) Yes No
If something new happens, does your child look at your face to see how you
feel about it? (For example, if he or she hears a strange or funny noise, or
sees a new toy, will he or she look at your face?) Yes No
Does your child like movement activities? (For example, being swung or
bounced on your knee) Yes No
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Consent Form for Human Participants in Research
University of Northern Colorado School of Nursing
Project Title: Autism Screening in Primary Care
Researcher: Elizabeth Shedd, BSN, DNP-S

Email: eibl6003@bears.unco.edu

Research Advisor: Karen Hessler, PhD, FNP

Email: karen.hessler@unco.edu

Phone #: 970-351-2137
Purpose and Description: Thank you for participating in this survey. These questions
concern basic clinician knowledge regarding screening for autism spectrum disorder in
primary care. The purpose of the survey is to further evaluate process improvement
outcomes as part of a DNP Capstone. Participating is not likely to be of any risk or
inconvenience to you, and should only take about 5-10 minutes of your time.
Once the study is completed, results will be shared with you if you desire. You are not
likely to experience any risks with completing the surveys, and there will not be any
compensation for doing so. Your consent form will not be stored with your responses,
and your name will not be on your surveys to help protect your anonymity. The survey’s
will be kept in a locked office in the school of nursing separated from your consent
forms, only accessible by the researcher and research advisor. If you have any questions
or concerns, please contact the researcher or the research advisor. The advisor may ask
your name, but all complaints are kept in confidence.
Participation is voluntary. You may decide not to participate in this study and if you
begin participation you may still decide to stop and withdraw at any time. Your decision
will be respected and will not result in loss of benefits to which you are otherwise
entitled. Having read the above and having had an opportunity to ask any questions,
please sign below if you would like to participate in this research. A copy of this form
will be given to you to retain for future reference. If you have any concerns about your
selection or treatment as a research participant, please contact Sherry May, IRB
Administrator, Office of Sponsored Programs, 25 Kepner Hall, University of Northern
Colorado Greeley, CO 80639; 970-351-1910.
Participant Signature and Date: _________________________________
Researcher Signature and Date: _________________________________
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GUIDELINE TITLE
Screening for autism spectrum disorder in primary care.
SUMMARY OF RECOMMENDATION AND EVIDENCE
The AAP concludes that there is still strong evidence to support universal screening for
autism spectrum disorder in primary care. This recommendation does take into
consideration the USPSTF recommendation stating there is insufficient evidence to
universally screen and more research must be conducted. However, there is strong
research to support the use of screening with tools such as the M-CHAT R and M-CHAT
R/F.
This type of level 1 screening is designed to be applied to a general population, and not
just those that exhibit symptoms. This helps to further prove that using general screening
for autism spectrum disorder along with primary surveillance, is key to early
identification. “This type of screening can identify children with significant
developmental and behavioral challenges early, when they may benefit most from
intervention, as well as those with other developmental difficulties” (Dreyer, 2016).
The current recommendation is as follows; universal screening for autism spectrum
disorder at 18 and 24 months well child exam using the M-CHAT R questionnaire
along with the age appropriate ASQ3. The M-CHAT R questionnaire should also be
conducted on new patients 5> with an unknown history and no access to previous
medical records. If the M-CHAT R and/or ASQ3 is abnormal or positive, the patient and
care-giver should return for a follow-up interview and appointment within one month.
This follow-up interview is conducted using the M-CHAT R/F and takes 15 minutes to
administer and score. If, after the follow-up interview the questionnaire indicates a high
risk for ASD, refer to the appropriate developmental and behavioral pediatrician AND
appropriate disability evaluation resources within the community (see algorithm 1 for
Greeley and surrounding areas). No matter the outcome of the M-CHAT R and/or MCHAT R/F continue developmental screening questionnaire until 5 years of age. Lastly,
regular developmental primary surveillance should be conducted at every appointment. If
for any abnormality noted on the general developmental screening (ASQ3) it is strongly
recommended that referral for disability evaluation occur and consider further evaluation
for developmental delay with The Children’s Hospital. Always consider further referral
for a complete audiology exam performed by a pediatric expert with any amount of
speech delay or parental concern for speech delay.
Screening TestsAccording to Bright Futures Guidelines for Health Supervision of Infants, Children, and
Adolescents the recommended screening test for autism spectrum disorder in primary
care is the M-CHAT R. This stands for Modified Checklist for Autism in ToddlersRevised. This screening tool takes five minutes to administer and score and can be
administered during normal developmental screening. If the M-CHAT R is positive or
increased risk for ASD the secondary screening tool that is to be administered at another
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appointment within one month is the M-CHAT R/F. This stands for Modified Checklist
for Autism in Toddlers Revised with Follow-up. These screening tools are parent-rated
scales that can indicate autism spectrum disorder signs and symptoms. Please see clinical
algorithm for further direction.
Treatments and InterventionsAutism spectrum disorder treatments and interventions include; behavioral, medical,
educational, language, and occupational therapy. The most effective therapy for those
with autism spectrum disorder is applied behavioral analysis. To qualify for applied
behavioral analysis a child requires an ASD diagnosis. However, to qualify for any other
appropriate therapies, a specific diagnosis isn’t required! This encourages prompt
evaluations to qualify for therapies. Appropriate therapy is jointly determined by the
diagnostic evaluation facility and the disability evaluation resource (either Early
Intervention or Child Find, based on the child’s age). Severity levels of disability is as
follows; level one- requires support, level two- requires substantial support, and level
three- requires very substantial support. If there is any provider concern, it is
recommended that referral occur for both or either resources for evaluations as the
“watch and wait approach” isn’t appropriate and can affect the child’s long-term
developmental trajectory. Prompt referral is key!
There are also many complementary and alternative medicine approaches to autism
spectrum disorder. Intense behavioral and developmental interventions improve the
health-related quality of life of those with autism spectrum disorder and care-givers.
Interventions can be delivered in a wide range of settings; home, school, group related
workshops, etc. The main goal of treatments and interventions for those with autism
spectrum disorder is early identification and prompt referral.
SUGGESTIONS FOR PRACTICE
Children’s Hospital Child Development and Behavioral Pediatrician’sPhone#: 720-777-6630
Fax#: 720-777-7868
Contact Information for Greeley 6Child Find (>3 years old):
Contact Person: Beth Dick MA, ECSE
Phone #: 970-475-1079
Fax #: 970-475-1090
Early Intervention of CO (<3 years old) (Envision CCB):
Contact Person: Desiree Lujan
Phone #: 970-313-2629
Fax#: 970-330-0153
Audiology: Audiology Associates of Greeley
Phone #: 970-352-2881
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Clinical PearlsIt’s important to remember that children develop at different times. With this said, good
documentation can help other providers know if milestones are being met. If you have
any questions about a delay in milestones, or other question related to childhood
behaviors and development call the pediatricians at Children’s Hospital Developmental
and Behavioral Department. See the contact information above.
Burden of DiseaseDelayed diagnosis of autism spectrum disorder affects the outcome of the child and
families forever. Early intervention is key to improve the health related quality of life.
• Prevalence of 7.6 per 1000 or one in 132 persons.
• Autism spectrum disorders account for substantial health loss across the
life span.
• National costs of autism at around $137 billion annually.
• Average lifetime cost of $1.4 million for a person affected by autism that
is not complicated by intellectual disability.
• Increasing prevalence.
• Increasing evidence for the role of genetic factors in the etiology of ASD.
• Environmental factors may constitute a "second-hit," modulating existing
genetic factors predisposing to ASD.
(Augustyn, M. (2016, July 3). Autism screening disorder: Terminology,
epidemiology, and pathogenesis. Retrieved from UpToDate: http://0www.uptodate.com.source.unco.edu/contents/autism-spectrum-disorderterminology-epidemiology-and-pathogenesis?source=search_result&
search=autism&selectedTitle=4~150.)
Potential HarmsWhen implementing a screening protocol, it’s important to consider the burden on those
administering and scoring the questionnaire. The M-CHAT R questionnaire takes 5
minutes to administer and score. The M-CHAT R/F takes 15 minutes to administer and
score. The 18 month and 24 month WCC are covered by Medicaid and other insurances.
With this screening guideline there is the potential for misdiagnosis and an increase in
anxiety related to having an abnormality on screening and subsequently further testing.
Because of resource restrictions it’s important to have referrals completed quickly. It can
take up to six months to get an appointment at the Sie Center at Children’s Hospital.
Useful Resourceshttps://www.autismspeaks.org/
https://m-chat.org/print.php
https://brightfutures.aap.org/bright%20Futures%20Documents/BF3%20pocket%20guide
_final.pdf
http://www.eicolorado.org/index.cfm?fuseaction=Documents.content&linkid=431
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https://www.cde.state.co.us/early/childfind
https://www.childrenscolorado.org/doctors-and-departments/departments/downsyndrome/our-team/
The M-CHAT R and M-CHAT R/F are available for free at https://www.mchat.org/print.php.
The USPSTF has made a recommendation on screening for speech and language delays
and disorders among children 5 years or younger (see the National Guideline
Clearinghouse [NGC] summary of the USPSTF guideline Screening for speech and
language delay and disorders in children aged 5 years or younger: U.S. Preventive
Services Task Force recommendation statement).
SEE CLINICAL TREATMENT ALGORYTHM FOR FURTHER DETAILS
SCOPE
Disease/Conditions:
Autism spectrum disorder (ASD)
Guideline Category:
Screening
Clinical Specialty:
Family Practice
Pediatrics
Development and Behavior
Neurology
Intended Users:
Advanced Practice Nurses
Health Care Providers
Nurses
Physician Assistants
Physicians
Guideline Objectives:
To provide recommendations on screening for autism spectrum disorder in young
children in a primary care.
Target Population:
Children aged 18 to 30 months or those <5 with unknown screening and no know
medical records who haven’t been diagnosed with autism spectrum disorder or other
developmental delays in primary care. Also, for those were no concerns for autism
spectrum disorder have been presented by care-givers.
Interventions and Practices Considered:
Screening for autism spectrum disorder in primary care using M-CHAT and M-CHAT
R/F.
METHODOLOGY
Methods Used to Collect Evidence:
Searches of electronic databases
Databases:
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CINAHL Plus with Full Text, Cochrane Central Register of Controlled Trials, Nursing
and Allied Health, PsycExtra, PsycInfo, Psychology and Behavioral Sciences, Psychiatry
Online, PubMed, and UpToDate.
Types of Evidence Supporting the Recommendations:
Systematic Reviews, expert opinion, and AAP recommendations
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